Thomas J. Walsh - Publications

Affiliations: 
Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Behavioral Neuroscience

57/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Lamprea MR, Cardenas FP, Silveira R, Walsh TJ, Morato S. Effects of septal cholinergic lesion on rat exploratory behavior in an open-field. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De Biofã­Sica ... [Et Al.]. 36: 233-8. PMID 12563526 DOI: 10.1590/S0100-879X2003000200011  0.387
2000 Lamprea MR, Cardenas FP, Silveira R, Morato S, Walsh TJ. Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behavioural Brain Research. 117: 97-105. PMID 11099762 DOI: 10.1016/S0166-4328(00)00294-1  0.412
2000 Herzog CD, Gandhi C, Bhattacharya P, Walsh TJ. Effects of intraseptal zolpidem and chlordiazepoxide on spatial working memory and high-affinity choline uptake in the hippocampus. Neurobiology of Learning and Memory. 73: 168-79. PMID 10704326 DOI: 10.1006/Nlme.1999.3928  0.431
2000 Gandhi CC, Kelly1 RM, Wiley RG, Walsh TJ. Impaired acquisition of a Morris water maze task following selective destruction of cerebellar purkinje cells with OX7-saporin. Behavioural Brain Research. 109: 37-47. PMID 10699656 DOI: 10.1016/S0166-4328(99)00160-6  0.437
1999 Guo-Ross SX, Yang EY, Walsh TJ, Bondy SC. Decrease of glial fibrillary acidic protein in rat frontal cortex following aluminum treatment. Journal of Neurochemistry. 73: 1609-14. PMID 10501207 DOI: 10.1046/J.1471-4159.1999.0731609.X  0.328
1998 Walsh TJ, Gandhi C, Stackman RW. Reversible inactivation of the medial septum or nucleus basalis impairs working memory in rats: A dissociation of memory and performance Behavioral Neuroscience. 112: 1114-1124. PMID 9829789 DOI: 10.1037//0735-7044.112.5.1114  0.471
1998 Dougherty KD, Turchin PI, Walsh TJ. Septocingulate and septohippocampal cholinergic pathways: involvement in working/episodic memory. Brain Research. 810: 59-71. PMID 9813241 DOI: 10.1016/S0006-8993(98)00870-1  0.437
1997 Otto T, Wolf D, Walsh TJ. Combined lesions of perirhinal and entorhinal cortex impair rats' performance in two versions of the spatially guided radial-arm maze. Neurobiology of Learning and Memory. 68: 21-31. PMID 9195586 DOI: 10.1006/Nlme.1997.3778  0.392
1996 Dougherty KD, Walsh TJ, Bailey S, Schlussman S, Grasing K. Acquisition of a morris water maze task is impaired during early but not late withdrawal from morphine. Pharmacology, Biochemistry, and Behavior. 55: 227-35. PMID 8951959 DOI: 10.1016/S0091-3057(96)00075-5  0.339
1996 Herzog CD, Stackman RW, Walsh TJ. Intraseptal flumazenil enhances, while diazepam binding inhibitor impairs, performance in a working memory task. Neurobiology of Learning and Memory. 66: 341-52. PMID 8946426 DOI: 10.1006/Nlme.1996.0074  0.476
1996 Dougherty KD, Salat D, Walsh TJ. Intraseptal injection of the cholinergic immunotoxin 192-IgG saporin fails to disrupt latent inhibition in a conditioned taste aversion paradigm. Brain Research. 736: 260-9. PMID 8930332 DOI: 10.1016/0006-8993(96)00712-3  0.347
1996 Walsh TJ, Herzog CD, Gandhi C, Stackman RW, Wiley RG. Injection of IgG 192-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits. Brain Research. 726: 69-79. PMID 8836547 DOI: 10.1016/0006-8993(96)00271-5  0.429
1996 Stackman RW, Walsh TJ, Brucato FH, Swartzwelder HS. Medial septal benzodiazepine receptors modulate hippocampal evoked responses and long-term potentiation Brain Research. 717: 12-21. PMID 8738248 DOI: 10.1016/0006-8993(95)01455-1  0.338
1995 Walsh TJ, Kelly RM, Dougherty KD, Stackman RW, Wiley RG, Kutscher CL. Behavioral and neurobiological alterations induced by the immunotoxin 192-IgG-saporin: cholinergic and non-cholinergic effects following i.c.v. injection. Brain Research. 702: 233-45. PMID 8846082 DOI: 10.1016/0006-8993(95)01050-X  0.412
1995 Stackman RW, Walsh TJ. Distinct profile of working memory errors following acute or chronic disruption of the cholinergic septohippocampal pathway Neurobiology of Learning and Memory. 64: 226-236. PMID 8564376 DOI: 10.1006/nlme.1995.0005  0.486
1995 Stackman RW, Walsh TJ. Anatomical specificity and time-dependence of chlordiazepoxide-induced spatial memory impairments Behavioral Neuroscience. 109: 436-445. PMID 7662154 DOI: 10.1037/0735-7044.109.3.436  0.444
1995 Janis LS, Glasier MM, Martin G, Stackman RW, Walsh TJ, Stein DG. A single intraseptal injection of nerve growth factor facilitates radial maze performance following damage to the medial septum in rats. Brain Research. 679: 99-109. PMID 7648270 DOI: 10.1016/0006-8993(95)00242-I  0.383
1994 Wortwein G, Stackman RW, Walsh TJ. Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A Experimental Neurology. 125: 15-21. PMID 8307121 DOI: 10.1006/exnr.1994.1002  0.4
1994 Stackman RW, Walsh TJ. Baclofen produces dose-related working memory impairments after intraseptal injection Behavioral and Neural Biology. 61: 181-185. PMID 8204084 DOI: 10.1016/S0163-1047(05)80073-1  0.462
1993 Walsh TJ, Stackman RW, Emerich DF, Taylor LA. Intraseptal injection of GABA and benzodiazepine receptor ligands alters high-affinity choline transport in the hippocampus. Brain Research Bulletin. 31: 267-71. PMID 8387864 DOI: 10.1016/0361-9230(93)90216-X  0.519
1993 Opello KD, Stackman RW, Ackerman S, Walsh TJ. AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task: Relation to cholinergic hypofunction Physiology and Behavior. 54: 1227-1233. PMID 7507594 DOI: 10.1016/0031-9384(93)90353-H  0.449
1992 Emerich DF, Black BA, Kesslak JP, Cotman CW, Walsh TJ. Transplantation of fetal cholinergic neurons into the hippocampus attenuates the cognitive and neurochemical deficits induced by AF64A. Brain Research Bulletin. 28: 219-26. PMID 1596741 DOI: 10.1016/0361-9230(92)90182-W  0.613
1992 Stackman RW, Walsh TJ. Chlordiazepoxide-induced working memory impairments: Site specificity and reversal by flumazenil (R015-1788) Behavioral and Neural Biology. 57: 233-243. PMID 1319705 DOI: 10.1016/0163-1047(92)90206-J  0.467
1991 Emerich DF, Walsh TJ. Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine. Experimental Neurology. 112: 328-37. PMID 2029933 DOI: 10.1016/0014-4886(91)90135-Y  0.648
1991 Chrobak JJ, Walsh TJ. Dose- and delay-dependent working/episodic memory impairments following intraventricular administration of ethylcholine aziridinium ion (AF64A). Behavioral and Neural Biology. 56: 200-12. PMID 1759941 DOI: 10.1016/0163-1047(91)90600-U  0.727
1991 Chrobak JJ, Napier TC, Hanin I, Walsh TJ. The pharmacology of basal forebrain involvement in cognition. Advances in Experimental Medicine and Biology. 295: 383-98. PMID 1723245 DOI: 10.1007/978-1-4757-0145-6_22  0.642
1990 Emerich DF, Walsh TJ. Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicine. Brain Research. 517: 157-67. PMID 2375986 DOI: 10.1016/0006-8993(90)91021-8  0.59
1990 Emerich DF, Walsh TJ. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A. Brain Research. 527: 299-307. PMID 2253037 DOI: 10.1016/0006-8993(90)91150-F  0.656
1990 Emerich DF, Walsh TJ. Hyperactivity following intradentate injection of colchicine: a role for dopamine systems in the nucleus accumbens. Pharmacology, Biochemistry, and Behavior. 37: 149-54. PMID 2124711 DOI: 10.1016/0091-3057(90)90055-M  0.564
1990 Walsh TJ, Emerich DF. Cholinotoxic effects of intraventricular colchicine: A new model of cholinergic hypofunction European Journal of Pharmacology. 183: 1928. DOI: 10.1016/0014-2999(90)92274-M  0.448
1989 Walsh TJ, Emerich DF, Schmechel DE. GM1 ganglioside attenuates the behavioral deficits but not the granule cell damage produced by intradentate colchicine. Brain Research. 478: 24-33. PMID 2924118 DOI: 10.1016/0006-8993(89)91473-X  0.604
1989 Walsh TJ, Emerich DF, Bondy SC. Destruction of specific hippocampal cell fields increases ornithine decarboxylase activity: modulation of the biochemical but not the histological changes by ganglioside GM1. Experimental Neurology. 105: 54-61. PMID 2744127 DOI: 10.1016/0014-4886(89)90171-4  0.559
1989 Emerich DF, Walsh TJ. Selective working memory impairments following intradentate injection of colchicine: attenuation of the behavioral but not the neuropathological effects by gangliosides GM1 and AGF2. Physiology & Behavior. 45: 93-101. PMID 2727146 DOI: 10.1016/0031-9384(89)90170-4  0.645
1989 Flaherty CF, Rowan GA, Emerich DF, Walsh TJ. Effects of intrahippocampal administration of colchicine on incentive contrast and on radial maze performance. Behavioral Neuroscience. 103: 319-28. PMID 2706077 DOI: 10.1037/0735-7044.103.2.319  0.614
1989 Chrobak JJ, Spates MJ, Stackman RW, Walsh TJ. Hemicholinium-3 prevents the working memory impairments and the cholinergic hypofunction induced by ethylcholine aziridinium ion (AF64A). Brain Research. 504: 269-75. PMID 2598029 DOI: 10.1016/0006-8993(89)91367-X  0.732
1989 Chrobak JJ, Stackman RW, Walsh TJ. Intraseptal administration of muscimol produces dose-dependent memory impairments in the rat. Behavioral and Neural Biology. 52: 357-69. PMID 2556105 DOI: 10.1016/S0163-1047(89)90472-X  0.725
1988 Walsh TJ, Emerich DF. The hippocampus as a common target of neurotoxic agents. Toxicology. 49: 137-40. PMID 3287689 DOI: 10.1016/0300-483X(88)90185-0  0.586
1988 Chrobak JJ, Hanin I, Schmechel DE, Walsh TJ. AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Research. 463: 107-17. PMID 3196899 DOI: 10.1016/0006-8993(88)90532-X  0.739
1988 DeHaven-Hudkins DL, Schulz DW, Walsh TJ, Mailman RB. Responses of dopaminergic and serotonergic systems to triethyllead intoxication. Neurotoxicology and Teratology. 10: 279-85. PMID 2465482 DOI: 10.1016/0892-0362(88)90029-3  0.477
1987 Chrobak JJ, Hanin I, Walsh TJ. AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task. Brain Research. 414: 15-21. PMID 3620916 DOI: 10.1016/0006-8993(87)91322-9  0.727
1987 Walsh TJ, Chrobak JJ. The use of the radial arm maze in neurotoxicology. Physiology & Behavior. 40: 799-803. PMID 3313454 DOI: 10.1016/0031-9384(87)90287-3  0.664
1986 Walsh TJ, Schulz DW, Tilson HA, Schmechel DE. Colchicine-induced granule cell loss in rat hippocampus: selective behavioral and histological alterations. Brain Research. 398: 23-36. PMID 3801898 DOI: 10.1016/0006-8993(86)91246-1  0.303
1985 Walsh TJ, Chrobak JJ, Tilson HA, Dehaven DL, Hanin I. AF64A produces long-term cognitive impairments following infusion into the lateral cerebral ventricles or the dorsal hippocampus: involvement of hippocampal cholinergic processes in learning and memory. Annals of the New York Academy of Sciences. 444: 538-40. PMID 3925852  0.655
1985 Chrobak JJ, DeHaven DL, Walsh TJ. Depletion of brain norepinephrine with DSP-4 does not alter acquisition or performance of a radial-arm maze task. Behavioral and Neural Biology. 44: 144-50. PMID 3834919 DOI: 10.1016/S0163-1047(85)91316-0  0.683
1984 Walsh TJ, Tilson HA, DeHaven DL, Mailman RB, Fisher A, Hanin I. AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat. Brain Research. 321: 91-102. PMID 6548653 DOI: 10.1016/0006-8993(84)90684-X  0.583
1984 DeHaven DL, Walsh TJ, Mailman RB. Effects of trimethyltin on dopaminergic and serotonergic function in the central nervous system. Toxicology and Applied Pharmacology. 75: 182-9. PMID 6206607 DOI: 10.1016/0041-008X(84)90200-X  0.504
1982 Walsh TJ, Miller DB, Dyer RS. Trimethyltin, a selective limbic system neurotoxicant, impairs radial-arm maze performance Neurobehavioral Toxicology and Teratology. 4: 177-183. PMID 7088245  0.303
1982 Walsh TJ, Gallagher M, Bostock E, Dyer RS. Trimethyltin impairs retention of a passive avoidance task. Neurobehavioral Toxicology and Teratology. 4: 163-7. PMID 7088244  0.377
1981 Walsh TJ, Palfai T. Reversal of guanethidine- and diethyldithiocarbamate-induced amnesia by peripherally-administered catecholamines. Pharmacology, Biochemistry, and Behavior. 14: 713-8. PMID 6264502 DOI: 10.1016/0091-3057(81)90136-2  0.545
1980 Palfai T, Walsh TJ. Comparisons of the effects of guanethidine, 6-hydroxydopamine and diethyldithiocarbamate on retention of passive avoidance. Pharmacology, Biochemistry, and Behavior. 13: 805-9. PMID 6259667 DOI: 10.1016/0091-3057(80)90211-7  0.594
1979 Walsh TJ, Palfai T. Memory storage impairment or retrieval failure: pharmacologically distinguishable processes. Pharmacology, Biochemistry, and Behavior. 11: 453-6. PMID 574972 DOI: 10.1016/0091-3057(79)90124-2  0.603
1979 Palfai T, Walsh TJ. Comparison of the long-term cumulative effects of reserpine and syrosingopine on general activity. Pharmacology, Biochemistry, and Behavior. 11: 585-7. PMID 43517 DOI: 10.1016/0091-3057(79)90046-7  0.526
1979 Palfai T, Walsh TJ. The role of peripheral catecholamines in reserpine-induced amnesia. Behavioral and Neural Biology. 27: 423-32. PMID 43124 DOI: 10.1016/S0163-1047(79)91998-8  0.564
1979 Walsh TJ, Palfai T. Peripheral catecholamines and memory: characteristics of syrosingopine-induced amnesia. Pharmacology, Biochemistry, and Behavior. 11: 449-52. PMID 42929 DOI: 10.1016/0091-3057(79)90123-0  0.587
1978 Walsh TJ, Palfai T. Time-dependent effects of reserpine on retention of passive avoidance. Pharmacology, Biochemistry, and Behavior. 8: 103-5. PMID 652819 DOI: 10.1016/0091-3057(78)90323-4  0.601
1978 Palfai T, Brown OM, Walsh TJ. Catecholamine levels in the whole brain and the probability of memory formation are not related. Pharmacology, Biochemistry, and Behavior. 8: 717-21. PMID 308663 DOI: 10.1016/0091-3057(78)90271-X  0.527
1977 Palfai T, Walsh TJ, Albala BJ, Brown OM. Effects of l-dihydroxyphenylalanine (l-Dopa) and d,l,5-hydroxytryptophan (d,l,5-HTP) on reserpine-induced amnesia Psychopharmacology. 53: 269-276. DOI: 10.1007/BF00492363  0.508
Low-probability matches (unlikely to be authored by this person)
1996 Gulyaeva NV, Lazareva NA, Libe ML, Mitrokhina OS, Onufriev MV, Stepanichev MYu, Chernysevskaya IA, Walsh TJ. Oxidative stress in the brain following intraventricular administration of ethylcholine aziridinium (AF64A). Brain Research. 726: 174-80. PMID 8836558 DOI: 10.1016/S0006-8993(96)00330-7  0.292
2015 Michini B, Walsh TJ, Agha-Mohammadi AA, How JP. Bayesian Nonparametric Reward Learning From Demonstration Ieee Transactions On Robotics. 31: 369-386. DOI: 10.1109/Tro.2015.2405593  0.288
2012 Walsh TJ, Littman ML, Borgida A. Learning web-service task descriptions from traces Web Intelligence and Agent Systems. 10: 397-421. DOI: 10.3233/Wia-2012-0254  0.287
1997 Stackman RW, Bartolomeo AC, Walsh TJ. Vitamin E attenuates the effects of both reversible and irreversible inhibitors of high-affinity choline transport in vivo. Restorative Neurology and Neuroscience. 11: 83-9. PMID 21551531 DOI: 10.3233/RNN-1997-111209  0.287
2000 Angner RT, Kelly RM, Wiley RG, Walsh TJ, Reuhl KR. Preferential destruction of cerebellar Purkinje cells by OX7-saporin Neurotoxicology. 21: 395-404. PMID 10894129  0.244
2011 Li L, Littman ML, Walsh TJ, Strehl AL. Knows what it knows: A framework for self-aware learning Machine Learning. 82: 399-443. DOI: 10.1007/S10994-010-5225-4  0.243
1985 Bondy SC, Hong JS, Tilson HA, Walsh TJ. Effects of triethyl lead on hot-plate responsiveness and biochemical properties of hippocampus Pharmacology, Biochemistry and Behavior. 22: 1007-1011. PMID 2991948 DOI: 10.1016/0091-3057(85)90310-7  0.242
2009 Walsh TJ, Nouri A, Li L, Littman ML. Learning and planning in environments with delayed feedback Autonomous Agents and Multi-Agent Systems. 18: 83-105. DOI: 10.1007/S10458-008-9056-7  0.236
2014 Chowdhary G, Liu M, Grande R, Walsh T, How J, Carin L. Off-policy reinforcement learning with Gaussian processes Ieee/Caa Journal of Automatica Sinica. 1: 227-238. DOI: 10.1109/Jas.2014.7004680  0.236
1986 Walsh TJ, McLamb RL, Bondy SC, Tilson HA, Chang LW. Triethyl and trimethyl lead: effects on behavior, CNS morphology and concentrations of lead in blood and brain of rat. Neurotoxicology. 7: 21-33. PMID 3822261  0.231
2015 Cutler M, Walsh TJ, How JP. Real-World Reinforcement Learning via Multifidelity Simulators Ieee Transactions On Robotics. DOI: 10.1109/Tro.2015.2419431  0.229
2011 Yaman F, Walsh TJ, Littman ML, Desjardins M. Democratic approximation of lexicographic preference models Artificial Intelligence. 175: 1290-1307. DOI: 10.1016/J.Artint.2010.11.012  0.229
1986 Walsh TJ, Schulz DW, Tilson HA, Dehaven DL. Acute exposure to triethyl lead enhances the behavioral effects of dopaminergic agonists: Involvement of brain dopamine in organolead neurotoxicity Brain Research. 363: 222-229. PMID 3942894 DOI: 10.1016/0006-8993(86)91007-3  0.225
2014 How JP, Chowdhary G, Walsh TJ. Special Issue on Aerospace and Mechanical Applications of Reinforcement Learning and Adaptive Learning Based Control Journal of Aerospace Information Systems. 11: 541-541. DOI: 10.2514/1.I010297  0.224
1984 Walsh TJ, Tilson HA. Neurobehavioral toxicology of the organoleads Neurotoxicology. 5: 67-86. PMID 6542981  0.222
1986 Walsh TJ, McLamb RL, Tilson HA. Novelty of the test environment contributes to the expression of triethyl lead-induced antinociception Neurobehavioral Toxicology and Teratology. 8: 311-315. PMID 3736761  0.222
2019 Day JH, Nicholson TM, Su X, van Neel TL, Clinton I, Kothandapani A, Lee J, Greenberg MH, Amory JK, Walsh TJ, Muller CH, Franco OE, Jefcoate CR, Crawford SE, Jorgensen JS, et al. Injection molded open microfluidic well plate inserts for user-friendly coculture and microscopy. Lab On a Chip. PMID 31712791 DOI: 10.1039/C9Lc00706G  0.22
1982 Ruppert PH, Walsh TJ, Reiter LW, Dyer RS. Trimethyltin-induced hyperactivity: time course and pattern Neurobehavioral Toxicology and Teratology. 4: 135-139. PMID 7201085  0.218
2016 Grande RC, Walsh TJ, Chowdhary G, Ferguson S, How JP. Online Regression for Data With Changepoints Using Gaussian Processes and Reusable Models. Ieee Transactions On Neural Networks and Learning Systems. PMID 27323379 DOI: 10.1109/Tnnls.2016.2574565  0.217
1993 Walsh TJ. Site-specific pharmacology for the treatment of Alzheimer's disease Experimental Neurology. 124: 43-46. PMID 8282078 DOI: 10.1006/exnr.1993.1172  0.205
1984 Johnson CT, Dunn A, Robinson C, Walsh TJ, Swartzwelder HS. Alterations in regulatory and locomotor behaviors following trimethyltin exposure in the rat: A time and dose analysis Neuroscience Letters. 47: 99-106. PMID 6462539 DOI: 10.1016/0304-3940(84)90413-0  0.205
2004 Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Research. 14: 1719-25. PMID 15342557 DOI: 10.1101/Gr.2855504  0.204
1992 Walsh T. Zero-bias anomalies in the current-voltage and conductance-voltage characteristics of high-critical-temperature superconductor junctions International Journal of Modern Physics B. 6: 125-170. DOI: 10.1142/S0217979292000098  0.198
1986 Wilson WE, Hudson PM, Kanamatsu T, Walsh TJ, Tilson HA, Hong JS, Marenpot RR, Thompson M. Trimethyltin-induced alterations in brain amino acids, amines and amine metabolites: relationship to hyperammonemia. Neurotoxicology. 7: 63-74. PMID 2434891  0.196
1991 Walsh T, Moreland J, Ono RH, Kalkur TS. Tunneling measurements of the zero-bias conductance peak and the Bi-Sr-Ca-Cu-O thin-film energy gap. Physical Review Letters. 66: 516-519. PMID 10043827 DOI: 10.1103/PhysRevLett.66.516  0.193
1984 Walsh TJ, McLamb RL, Tilson HA. Organometal-induced antinociception: A time- and dose-response comparison of triethyl and trimethyl lead and tin Toxicology and Applied Pharmacology. 73: 295-299. PMID 6710529 DOI: 10.1016/0041-008X(84)90335-1  0.191
1991 Walsh T, Moreland J, Ono RH, Kalkur TS. Bi-Sr-Ca-Cu-O thin-film energy gap as a function of temperature and force applied to squeezable-electron-tunneling junctions. Physical Review. B, Condensed Matter. 43: 11492-11495. PMID 9996910 DOI: 10.1103/Physrevb.43.11492  0.19
1986 Walsh TJ, McLamb RL, Tilson HA. A comparison of the effects of RO15,1788 and chlordiazepoxide on hot-plate latencies, acoustic startle, and locomotor activity Psychopharmacology. 88: 514-519. PMID 3085141 DOI: 10.1007/BF00178517  0.184
2002 Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, et al. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. American Journal of Human Genetics. 71: 1395-412. PMID 12454801 DOI: 10.1086/345075  0.182
1987 Walsh TJ, Wagner WT, Donnelly RJ. Stability of modulated Couette flow. Physical Review Letters. 58: 2543-2546. PMID 10034779 DOI: 10.1103/Physrevlett.58.2543  0.176
1982 Dyer RS, Walsh TJ, Wonderlin WF, Bercegeay M. The trimethyltin syndrome in rats Neurobehavioral Toxicology and Teratology. 4: 127-133. PMID 7201084  0.176
1988 Walsh TJ, Donnelly RJ. Taylor-Couette flow with periodically corotated and counterrotated cylinders. Physical Review Letters. 60: 700-703. PMID 10038624 DOI: 10.1103/Physrevlett.60.700  0.173
1992 Walsh TJ, Opello KD. Neuroplasticity, the aging brain, and Alzheimer's disease Neurotoxicology. 13: 101-110. PMID 1508410  0.169
2004 Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA, Sein T, Mickiene D, Bacher J, Groll AH, Walsh TJ. Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. Antimicrobial Agents and Chemotherapy. 48: 3959-67. PMID 15388459 DOI: 10.1128/AAC.48.10.3959-3967.2004  0.168
2020 Petraitiene R, Petraitis V, Kavaliauskas P, Maung BBW, Khan F, Naing E, Aung T, Zigmantaite V, Grigaleviciute R, Kucinskas A, Stakauskas R, Georgiades BN, Mazur CA, Hayden JA, Satlin MJ, ... Walsh TJ, et al. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Carbapenemase-Producing (KPC-) in Persistently Neutropenic Rabbits. Antimicrobial Agents and Chemotherapy. PMID 32015048 DOI: 10.1128/AAC.02157-19  0.162
2005 Petraitiene R, Petraitis V, Kelaher AM, Sarafandi AA, Mickiene D, Groll AH, Sein T, Bacher J, Walsh TJ. Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits. Antimicrobial Agents and Chemotherapy. 49: 2084-92. PMID 15855534 DOI: 10.1128/AAC.49.5.2084-2092.2005  0.161
2012 Warn PA, Livermore J, Howard S, Felton TW, Sharp A, Gregson L, Goodwin J, Petraitiene R, Petraitis V, Cohen-Wolkowiez M, Walsh TJ, Benjamin DK, Hope WW. Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach. Antimicrobial Agents and Chemotherapy. 56: 708-14. PMID 22123680 DOI: 10.1128/AAC.05826-11  0.158
1982 Howell WE, Walsh TJ, Dyer RS. Somatosensory dysfunction following acute trimethyltin exposure Neurobehavioral Toxicology and Teratology. 4: 197-201. PMID 7088248  0.156
1982 Dyer RS, Wonderlin WF, Walsh TJ. Increased seizure susceptibility following trimethyltin administration in rats Neurobehavioral Toxicology and Teratology. 4: 203-208. PMID 7088249  0.152
2007 Hope WW, Drusano GL, Moore CB, Sharp A, Louie A, Walsh TJ, Denning DW, Warn PA. Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis. Antimicrobial Agents and Chemotherapy. 51: 285-95. PMID 17088486 DOI: 10.1128/AAC.00601-06  0.144
2002 Petraitis V, Petraitiene R, Groll AH, Roussillon K, Hemmings M, Lyman CA, Sein T, Bacher J, Bekersky I, Walsh TJ. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrobial Agents and Chemotherapy. 46: 1857-69. PMID 12019101 DOI: 10.1128/AAC.46.6.1857-1869.2002  0.143
2019 Petraitis V, Petraitiene R, Valdez JM, Pyrgos V, Lizak MJ, Klaunberg BA, Kalasauskas D, Basevicius A, Bacher JD, Benjamin DK, Hope WW, Walsh TJ. Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous Meningoencephalitis. Antimicrobial Agents and Chemotherapy. PMID 31591128 DOI: 10.1128/AAC.01626-19  0.139
2006 Würthwein G, Groll AH, Hempel G, Adler-Shohet FC, Lieberman JM, Walsh TJ. Population pharmacokinetics of amphotericin B lipid complex in neonates. Antimicrobial Agents and Chemotherapy. 49: 5092-8. PMID 16304177 DOI: 10.1128/AAC.49.12.5092-5098.2005  0.138
2004 Groll AH, Mickiene D, Petraitis V, Petraitiene R, Alfaro RM, King C, Piscitelli SC, Walsh TJ. Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits. Antimicrobial Agents and Chemotherapy. 47: 3917-25. PMID 14638502 DOI: 10.1128/AAC.47.12.3917-3925.2003  0.136
1994 Walsh TJ, Kelly RM, Stackman RW. Strategies to limit brain injury and promote recovery of function Neurotoxicology. 15: 467-476. PMID 7854580  0.135
2004 Walsh TJ, Karlsson MO, Driscoll T, Arguedas AG, Adamson P, Saez-Llorens X, Vora AJ, Arrieta AC, Blumer J, Lutsar I, Milligan P, Wood N. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrobial Agents and Chemotherapy. 48: 2166-72. PMID 15155217 DOI: 10.1128/AAC.48.6.2166-2172.2004  0.135
2005 Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, Schwartz C, Shad A, Kaplan SL, Roden MM, Stone JA, Miller A, Bradshaw SK, Li SX, Sable CA, Kartsonis NA. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrobial Agents and Chemotherapy. 49: 4536-45. PMID 16251293 DOI: 10.1128/AAC.49.11.4536-4545.2005  0.135
1986 Sloviter RS, von Knebel Doeberitz C, Walsh TJ, Dempster DW. On the role of seizure activity in the hippocampal damage produced by trimethyltin. Brain Research. 367: 169-82. PMID 3697698 DOI: 10.1016/0006-8993(86)91590-8  0.135
2010 Benjamin DK, Smith PB, Arrieta A, Castro L, Sánchez PJ, Kaufman D, Arnold LJ, Kovanda LL, Sawamoto T, Buell DN, Hope WW, Walsh TJ. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clinical Pharmacology and Therapeutics. 87: 93-9. PMID 19890251 DOI: 10.1038/clpt.2009.200  0.134
2005 Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrobial Agents and Chemotherapy. 49: 3317-24. PMID 16048942 DOI: 10.1128/AAC.49.8.3317-3324.2005  0.134
2016 Petraitis V, Petraitiene R, Moradi PW, Strauss GE, Katragkou A, Kovanda LL, Hope WW, Walsh TJ. Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. PMID 26883703 DOI: 10.1128/AAC.02665-15  0.132
2022 Wurman PR, Barrett S, Kawamoto K, MacGlashan J, Subramanian K, Walsh TJ, Capobianco R, Devlic A, Eckert F, Fuchs F, Gilpin L, Khandelwal P, Kompella V, Lin H, MacAlpine P, et al. Outracing champion Gran Turismo drivers with deep reinforcement learning. Nature. 602: 223-228. PMID 35140384 DOI: 10.1038/s41586-021-04357-7  0.13
2016 Seibel NL, Shad AT, Bekersky I, Groll AH, Gonzalez C, Wood LV, Jarosinski P, Buell D, Hope WW, Walsh TJ. Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients. Antimicrobial Agents and Chemotherapy. PMID 27855062 DOI: 10.1128/AAC.01477-16  0.128
2012 Moriyama B, Henning SA, Leung J, Falade-Nwulia O, Jarosinski P, Penzak SR, Walsh TJ. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases. Mycoses. 55: 290-7. PMID 22126626 DOI: 10.1111/j.1439-0507.2011.02158.x  0.126
2004 Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ. Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrobial Agents and Chemotherapy. 48: 1188-96. PMID 15047519 DOI: 10.1128/AAC.48.4.1188-1196.2004  0.126
2009 Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrobial Agents and Chemotherapy. 53: 2382-91. PMID 19307368 DOI: 10.1128/AAC.00329-09  0.126
2018 Lee JH, Moriyama B, Henning SA, Danner RL, Walsh TJ, Penzak SR, Grimes GJ, Potti GK. Stability of isoniazid injection in i.v. solutions. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 75: 622-626. PMID 29748300 DOI: 10.2146/ajhp170268  0.126
2003 Groll AH, Wood L, Roden M, Mickiene D, Chiou CC, Townley E, Dad L, Piscitelli SC, Walsh TJ. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis. Antimicrobial Agents and Chemotherapy. 46: 2554-63. PMID 12121932 DOI: 10.1128/AAC.46.8.2554-2563.2002  0.125
2011 Saoulidis S, Simitsopoulou M, Dalakiouridou M, Walsh TJ, Wheat LJ, Papaioannidou P, Roilides E. Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model. Mycoses. 54: e486-92. PMID 21039940 DOI: 10.1111/j.1439-0507.2010.01958.x  0.125
1995 Yurdaydin C, Walsh TJ, Engler HD, Ha JH, Li Y, Jones EA, Basile AS. Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy. Brain Research. 679: 42-8. PMID 7648264 DOI: 10.1016/0006-8993(95)00241-H  0.124
2017 Bulman ZP, Satlin MJ, Chen L, Kreiswirth BN, Shin BS, Walsh TJ, Holden PN, Forrest A, Nation RL, Li J, Tsuji BT. Polymyxin B-Based Triple Combinations Wage War Against KPC-2-producing Klebsiella pneumoniae: New Dosing Strategies for Old Allies. Antimicrobial Agents and Chemotherapy. PMID 28167549 DOI: 10.1128/Aac.02023-16  0.122
2002 Bondy SC, Yang YE, Walsh TJ, Gie YW, Lahiri DK. Dietary modulation of age-related changes in cerebral pro-oxidant status Neurochemistry International. 40: 123-130. PMID 11738478 DOI: 10.1016/S0197-0186(01)00084-5  0.121
2021 Petraitis V, Petraitiene R, Kavaliauskas P, Naing E, Garcia A, Sutherland C, Kau AY, Goldner N, Bulow C, Nicolau DP, Walsh TJ. Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-001 (Meropenem/Piperacillin/Tazobactam) for Treatment of Methicillin-Resistant Bacteremia in Immunocompetent Rabbits with Chronic Indwelling Vascular Catheters. Antimicrobial Agents and Chemotherapy. AAC0116821. PMID 34460301 DOI: 10.1128/AAC.01168-21  0.121
2014 Farmakiotis D, Shirazi F, Zhao Y, Saad PJ, Albert ND, Roilides E, Walsh TJ, Perlin DS, Kontoyiannis DP. Methylprednisolone enhances the growth of Exserohilum rostratum in vitro, attenuates spontaneous apoptosis, and increases mortality rates in immunocompetent Drosophila flies. The Journal of Infectious Diseases. 210: 1471-5. PMID 24837401 DOI: 10.1093/infdis/jiu289  0.12
2019 Adler-Moore J, Lewis RE, Brüggemann RJM, Rijnders BJA, Groll AH, Walsh TJ. Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 68: S244-S259. PMID 31222254 DOI: 10.1093/Cid/Ciz064  0.118
2002 Petraitiene R, Petraitis V, Groll AH, Sein T, Schaufele RL, Francesconi A, Bacher J, Avila NA, Walsh TJ. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrobial Agents and Chemotherapy. 46: 12-23. PMID 11751105 DOI: 10.1128/AAC.46.1.12-23.2002  0.118
2022 Petraitis V, Petraitiene R, Kavaliauskas P, Naing E, Garcia A, Georgiades BN, Echols R, Bonomo RA, Yamano Y, Satlin MJ, Walsh TJ. Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits. Antimicrobial Agents and Chemotherapy. e0061822. PMID 36154614 DOI: 10.1128/aac.00618-22  0.118
2018 Petraitis V, Petraitiene R, Maung BBW, Khan F, Alisauskaite I, Olesky M, Newman J, Mutlib A, Niu X, Satlin M, Singh RS, Derendorf H, Walsh TJ. Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits. Antimicrobial Agents and Chemotherapy. PMID 29941646 DOI: 10.1128/Aac.00275-18  0.117
2007 Groll AH, Walsh TJ. Posaconazole: clinical pharmacology and potential for management of fungal infections. Expert Review of Anti-Infective Therapy. 3: 467-87. PMID 16107193 DOI: 10.1586/14787210.3.4.467  0.117
2020 Petraitis V, Petraitiene R, Katragkou A, Maung BBW, Naing E, Kavaliauskas P, Barat S, Borroto-Esoda K, Azie N, Angulo D, Walsh TJ. Combination Therapy with Ibrexafungerp (formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-D-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. PMID 32179521 DOI: 10.1128/AAC.02429-19  0.117
2007 Meletiadis J, Antachopoulos C, Stergiopoulou T, Pournaras S, Roilides E, Walsh TJ. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology. Antimicrobial Agents and Chemotherapy. 51: 3329-37. PMID 17576838 DOI: 10.1128/AAC.00345-07  0.116
2011 Chatzimoschou A, Katragkou A, Simitsopoulou M, Antachopoulos C, Georgiadou E, Walsh TJ, Roilides E. Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrobial Agents and Chemotherapy. 55: 1968-74. PMID 21343465 DOI: 10.1128/AAC.00959-10  0.116
2020 Petraitis V, Petraitiene R, Katragkou A, Maung BBW, Moradi PW, Sussman-Straus GE, Naing E, Kovanda LL, Finkelman MA, Walsh TJ. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis. Medical Mycology. PMID 33313821 DOI: 10.1093/mmy/myaa102  0.116
2012 Meletiadis J, Al-Saigh R, Velegraki A, Walsh TJ, Roilides E, Zerva L. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model. Antimicrobial Agents and Chemotherapy. 56: 403-10. PMID 22064546 DOI: 10.1128/AAC.00662-11  0.115
2008 Tantiwongse K, Fandel TM, Wang G, Breyer BN, Walsh TJ, Bella AJ, Lue TF. The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats. Bju International. 102: 242-6. PMID 18336614 DOI: 10.1111/j.1464-410X.2008.07582.x  0.115
2020 Gastine S, Hope W, Hempel G, Petraitiene R, Petraitis V, Mickiene D, Bacher J, Walsh TJ, Groll AH. Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy. Antimicrobial Agents and Chemotherapy. PMID 33168606 DOI: 10.1128/AAC.01574-20  0.114
2004 Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A, Murray H, Mya-San C, Bacher J, Petraitis V. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. Journal of Clinical Microbiology. 42: 4744-8. PMID 15472335 DOI: 10.1128/JCM.42.10.4744-4748.2004  0.114
2015 Simitsopoulou M, Walsh TJ, Kyrpitzi D, Petraitis V, Kontoyiannis DP, Perlin DS, Roilides E. Methylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum. Medical Mycology. 53: 189-93. PMID 25056961 DOI: 10.1093/mmy/myu034  0.114
2006 Hope WW, Warn PA, Sharp A, Howard S, Kasai M, Louie A, Walsh TJ, Drusano GL, Denning DW. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect. Antimicrobial Agents and Chemotherapy. 50: 3680-8. PMID 16954320 DOI: 10.1128/Aac.00369-06  0.114
2009 Smith PB, Walsh TJ, Hope W, Arrieta A, Takada A, Kovanda LL, Kearns GL, Kaufman D, Sawamoto T, Buell DN, Benjamin DK. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. The Pediatric Infectious Disease Journal. 28: 412-5. PMID 19319022 DOI: 10.1097/INF.0b013e3181910e2d  0.112
2007 Hope WW, Warn PA, Sharp A, Reed P, Keevil B, Louie A, Walsh TJ, Denning DW, Drusano GL. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing. Antimicrobial Agents and Chemotherapy. 51: 3760-2. PMID 17682101 DOI: 10.1128/AAC.00488-07  0.112
2022 Smith NM, Boissonneault KR, Chen L, Petraitis V, Petraitiene R, Tao X, Zhou J, Lang Y, Kavaliauskas P, Bulman ZP, Holden PN, Cha R, Bulitta JB, Kreiswirth BN, Walsh TJ, et al. Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity. Antimicrobial Agents and Chemotherapy. e0052722. PMID 35924913 DOI: 10.1128/aac.00527-22  0.112
2019 Petraitis V, Petraitiene R, Naing E, Aung T, Thi WP, Kavaliauskas P, Maung BBW, Michel AO, Ricart Arbona RJ, DeRyke AC, Culshaw DL, Nicolau DP, Satlin MJ, Walsh TJ. Ceftolozane/Tazobactam in the Treatment of Experimental Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains with Genetically Defined Mechanisms of Resistance. Antimicrobial Agents and Chemotherapy. PMID 31235620 DOI: 10.1128/AAC.00344-19  0.111
2014 Small KW, Chan CK, Silva-Garcia R, Walsh TJ. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone. Ophthalmology. 121: 952-8. PMID 24507858 DOI: 10.1016/j.ophtha.2013.10.040  0.111
2004 van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, Bunin N, Wall DA, Hiemenz JW, Satoi Y, Lee JM, Walsh TJ. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 1407-16. PMID 15546073 DOI: 10.1086/422312  0.11
2006 Dennis CG, Greco WR, Brun Y, Youn R, Slocum HK, Bernacki RJ, Lewis R, Wiederhold N, Holland SM, Petraitiene R, Walsh TJ, Segal BH. Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease. Antimicrobial Agents and Chemotherapy. 50: 422-7. PMID 16436692 DOI: 10.1128/Aac.50.2.422-427.2006  0.11
2010 Walsh TJ, Driscoll T, Milligan PA, Wood ND, Schlamm H, Groll AH, Jafri H, Arrieta AC, Klein NJ, Lutsar I. Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children. Antimicrobial Agents and Chemotherapy. 54: 4116-23. PMID 20660687 DOI: 10.1128/AAC.00896-10  0.109
1982 Walsh TJ, Tilson HA. A comparison of the behavioral effects of organic and inorganic lead Neurotoxicology. 3: 121-122.  0.109
2014 Gamaletsou MN, Daikos GL, Walsh TJ, Perlin DS, Ortigosa CJ, Psaroulaki A, Pagoni M, Argyropoulou A, Nepka M, Perivolioti E, Kotsopoulou M, Perloretzou S, Marangos M, Kofteridis D, Grammatikou M, et al. Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints. International Journal of Antimicrobial Agents. 44: 248-55. PMID 25108876 DOI: 10.1016/j.ijantimicag.2014.05.015  0.109
2011 De Lucca AJ, Boue S, Sien T, Cleveland TE, Walsh TJ. Silver enhances the in vitro antifungal activity of the saponin, CAY-1. Mycoses. 54: e1-9. PMID 20002309 DOI: 10.1111/j.1439-0507.2009.01811.x  0.108
2018 Bulman ZP, Zhao M, Satlin MJ, Chen L, Kreiswirth BN, Walsh TJ, Nation RL, Li J, Tsuji BT. Polymyxin B and Fosfomycin Thwart KPC-producing Klebsiella pneumoniae in the Hollow Fibre Infection Model. International Journal of Antimicrobial Agents. PMID 29486233 DOI: 10.1016/J.Ijantimicag.2018.02.010  0.108
2010 Hope WW, Smith PB, Arrieta A, Buell DN, Roy M, Kaibara A, Walsh TJ, Cohen-Wolkowiez M, Benjamin DK. Population pharmacokinetics of micafungin in neonates and young infants. Antimicrobial Agents and Chemotherapy. 54: 2633-7. PMID 20308367 DOI: 10.1128/AAC.01679-09  0.107
2020 Walsh TJ, Petraitiene R, Petraitis V. Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets? Journal of Fungi (Basel, Switzerland). 6. PMID 33007839 DOI: 10.3390/jof6040198  0.107
2007 Kontny U, Walsh TJ, Rossler J, Uhl M, Niemeyer CM. Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia. Pediatric Blood & Cancer. 49: 360-2. PMID 16444677 DOI: 10.1002/pbc.20751  0.107
2010 Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients. Antimicrobial Agents and Chemotherapy. 54: 3451-9. PMID 20439610 DOI: 10.1128/AAC.01647-09  0.106
2008 Petraitiene R, Petraitis V, Hope WW, Mickiene D, Kelaher AM, Murray HA, Mya-San C, Hughes JE, Cotton MP, Bacher J, Walsh TJ. Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrobial Agents and Chemotherapy. 52: 4121-9. PMID 18779361 DOI: 10.1128/AAC.00674-08  0.106
2005 Yamagishi H, Fitzgerald DH, Sein T, Walsh TJ, O'Connell BC. Saliva affects the antifungal activity of exogenously added histatin 3 towards Candida albicans. Fems Microbiology Letters. 244: 207-12. PMID 15727842 DOI: 10.1016/j.femsle.2005.01.045  0.106
2015 Fisher BT, Vendetti N, Bryan M, Prasad PA, Russell Localio A, Damianos A, Coffin SE, Bell LM, Walsh TJ, Gross R, Zaoutis TE. Central Venous Catheter Retention and Mortality in Children With Candidemia: A Retrospective Cohort Analysis. Journal of the Pediatric Infectious Diseases Society. PMID 26407279 DOI: 10.1093/Jpids/Piv048  0.106
2002 Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrobial Agents and Chemotherapy. 46: 828-33. PMID 11850268 DOI: 10.1128/AAC.46.3.828-833.2002  0.105
2020 Petraitiene R, Petraitis V, Maung BW, Naing E, Kavaliauskas P, Walsh TJ. Posaconazole Alone and in Combination with Caspofungin for Treatment of Experimental Meningoencephalitis: Developing New Strategies for Treatment of Phaeohyphomycosis of the Central Nervous System. Journal of Fungi (Basel, Switzerland). 6. PMID 32150900 DOI: 10.3390/jof6010033  0.105
2010 Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ, Champlin RE, Raad II. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine. 89: 236-44. PMID 20616663 DOI: 10.1097/MD.0b013e3181e9441b  0.104
2017 Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, ... ... Walsh TJ, et al. Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia: Implications for Optimal Antimicrobial Therapy Ventilator-Associated Bacterial Pneumonia Study Group. Antimicrobial Agents and Chemotherapy. PMID 29038277 DOI: 10.1128/Aac.01323-17  0.103
2011 Simitsopoulou M, Roilides E, Walsh TJ. Immunomodulatory properties of antifungal agents on phagocytic cells. Immunological Investigations. 40: 809-24. PMID 21985307 DOI: 10.3109/08820139.2011.615877  0.103
2006 Groll AH, Lyman CA, Petraitis V, Petraitiene R, Armstrong D, Mickiene D, Alfaro RM, Schaufele RL, Sein T, Bacher J, Walsh TJ. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations. Antimicrobial Agents and Chemotherapy. 50: 3418-23. PMID 17005824 DOI: 10.1128/AAC.00241-06  0.103
2020 Liston SD, Whitesell L, McLellan CA, Mazitschek R, Petraitis V, Petraitiene R, Kavaliauskas P, Walsh TJ, Cowen LE. Antifungal activity of gepinacin-scaffold GPI anchor biosynthesis inhibitors with improved metabolic stability. Antimicrobial Agents and Chemotherapy. PMID 32661007 DOI: 10.1128/Aac.00899-20  0.1
2015 Al-Nakeeb Z, Petraitis V, Goodwin J, Petraitiene R, Walsh TJ, Hope WW. Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 59: 2735-45. PMID 25712363 DOI: 10.1128/AAC.04723-14  0.099
2020 Ghannoum M, Arendrup MC, Chaturvedi VP, Lockhart SR, McCormick TS, Chaturvedi S, Berkow EL, Juneja D, Tarai B, Azie N, Angulo D, Walsh TJ. Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Infections. Antibiotics (Basel, Switzerland). 9. PMID 32854252 DOI: 10.3390/antibiotics9090539  0.099
2004 Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. The Journal of Infectious Diseases. 190: 641-9. PMID 15243943 DOI: 10.1086/422009  0.099
2010 Antachopoulos C, Demchok JP, Roilides E, Walsh TJ. Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi. Mycoses. 53: 321-8. PMID 19638003 DOI: 10.1111/j.1439-0507.2009.01725.x  0.098
2010 Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, Gersten ID, Mendizabal AM, Leather HL, Confer DL, Maziarz RT, Stadtmauer EA, Bolaños-Meade J, Brown J, Dipersio JF, et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood. 116: 5111-8. PMID 20826719 DOI: 10.1182/blood-2010-02-268151  0.098
2015 Katragkou A, Alexander EL, Eoh H, Raheem SK, Roilides E, Walsh TJ. Effects of fluconazole on the metabolomic profile of Candida albicans. The Journal of Antimicrobial Chemotherapy. PMID 26668236 DOI: 10.1093/jac/dkv381  0.097
2011 Cohen-Wolkowiez M, Benjamin DK, Piper L, Cheifetz IM, Moran C, Liu P, Aram J, Kashuba AD, Capparelli E, Walsh TJ, Hope WW, Smith PB. Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates. Clinical Pharmacology and Therapeutics. 89: 702-7. PMID 21412233 DOI: 10.1038/clpt.2011.26  0.097
2022 Gastine S, Hempel G, Neely MN, Walsh TJ, Groll AH. Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients. The Journal of Antimicrobial Chemotherapy. PMID 35696555 DOI: 10.1093/jac/dkac182  0.095
1999 Callender DP, Jayaprakash N, Bell A, Petraitis V, Petraitiene R, Candelario M, Schaufele R, Dunn JM, Sei S, Walsh TJ, Balis FM, Petratienes R. Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheres in rabbits. Antimicrobial Agents and Chemotherapy. 43: 972-4. PMID 10103214 DOI: 10.1128/AAC.43.4.972  0.095
2019 Gamaletsou MN, Meletiadis J, Chatziioannou S, Panayiotides IG, Agadakos E, Katsimpoulas M, Kostomitsopoulos N, Petraitis V, Walsh TJ, Sipsas NV. Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model. Medical Mycology. PMID 30753591 DOI: 10.1093/mmy/myz001  0.094
2009 Estes KE, Penzak SR, Calis KA, Walsh TJ. Pharmacology and antifungal properties of anidulafungin, a new echinocandin. Pharmacotherapy. 29: 17-30. PMID 19113794 DOI: 10.1592/phco.29.1.17  0.094
2017 Bulman ZP, Chen L, Walsh TJ, Satlin MJ, Qian Y, Bulitta JB, Peloquin CA, Holden PN, Nation RL, Li J, Kreiswirth BN, Tsuji BT. Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and blaNDM-5: Preparation for a Postantibiotic Era. Mbio. 8. PMID 28743810 DOI: 10.1128/Mbio.00540-17  0.093
2012 Moriyama B, Henning SA, Penzak SR, Walsh TJ. The postantifungal and paradoxical effects of echinocandins against Candida spp. Future Microbiology. 7: 565-9. PMID 22568712 DOI: 10.2217/fmb.12.31  0.093
2003 Gil-Lamaignere C, Roilides E, Mosquera J, Maloukou A, Walsh TJ. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrobial Agents and Chemotherapy. 46: 2234-7. PMID 12069979 DOI: 10.1128/AAC.46.7.2234-2237.2002  0.093
2005 Shaukat A, Bakri F, Young P, Hahn T, Ball D, Baer MR, Wetzler M, Slack JL, Loud P, Czuczman M, McCarthy PL, Walsh TJ, Segal BH. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia. 159: 181-8. PMID 15770441 DOI: 10.1007/S11046-004-5495-0  0.093
2014 Simitsopoulou M, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii. Antimicrobial Agents and Chemotherapy. 58: 4953-6. PMID 24890585 DOI: 10.1128/AAC.03117-14  0.092
2008 Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrobial Agents and Chemotherapy. 52: 321-8. PMID 17938191 DOI: 10.1128/AAC.00699-07  0.092
2003 Bennett JE, Powers J, Walsh T, Viscoli C, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Kauffman C, Lee J, Pappas P, Rex J, Verweij P. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: S117-22. PMID 12679895 DOI: 10.1086/367839  0.092
2017 Petraitis V, Petraitiene R, McCarthy MW, Kovanda LL, Zaw MH, Hussain K, Shaikh N, Maung BBW, Sekhon NK, Hope WW, Walsh TJ. Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. PMID 28696236 DOI: 10.1128/AAC.00305-17  0.092
2004 Roilides E, Walsh T. Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp. Medical Mycology. 42: 1-13. PMID 14982109 DOI: 10.1080/13693780310001631341  0.091
2008 Stergiopoulou T, De Lucca AJ, Meletiadis J, Sein T, Boue SM, Schaufele R, Roilides E, Ghannoum M, Walsh TJ. In vitro activity of CAY-1, a saponin from Capsicum frutescens, against Microsporum and Trichophyton species. Medical Mycology. 46: 805-10. PMID 18608885 DOI: 10.1080/13693780802089831  0.091
2015 Petraitiene R, Petraitis V, Hope WW, Walsh TJ. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: S643-51. PMID 26567283 DOI: 10.1093/cid/civ817  0.091
2022 Zagaliotis P, Petrou A, Mystridis GA, Geronikaki A, Vizirianakis IS, Walsh TJ. Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences. 23. PMID 35887353 DOI: 10.3390/ijms23148006  0.091
2023 Samdavid Thanapaul RJR, Roberds A, Rios KE, Walsh TJ, Bobrov AG. Hyphae of and Are More Virulent and Resistant to Antifungal Agents Than Sporangiospores In Vitro and in . Journal of Fungi (Basel, Switzerland). 9. PMID 37888214 DOI: 10.3390/jof9100958  0.09
2003 Cortez KJ, Walsh TJ, Bennett JE. Successful treatment of coccidioidal meningitis with voriconazole. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: 1619-22. PMID 12802765 DOI: 10.1086/375235  0.09
2017 Taj-Aldeen SJ, Gamaletsou MN, Rammaert B, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Henry M, Petraitis V, Moriyama B, Denning DW, Lortholary O, Walsh TJ. Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century. Medical Mycology. PMID 28053147 DOI: 10.1093/mmy/myw136  0.09
2004 Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents : pharmacokinetics, safety and efficacy. Drugs. 64: 1997-2020. PMID 15341494 DOI: 10.2165/00003495-200464180-00001  0.09
2010 Meletiadis J, Pournaras S, Roilides E, Walsh TJ. Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 54: 602-9. PMID 19995928 DOI: 10.1128/AAC.00999-09  0.09
2014 Moriyama B, Gordon LA, McCarthy M, Henning SA, Walsh TJ, Penzak SR. Emerging drugs and vaccines for candidemia. Mycoses. 57: 718-33. PMID 25294098 DOI: 10.1111/myc.12265  0.09
2014 Krel M, Petraitis V, Petraitiene R, Jain MR, Zhao Y, Li H, Walsh TJ, Perlin DS. Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic response. Antimicrobial Agents and Chemotherapy. 58: 3373-8. PMID 24687510 DOI: 10.1128/AAC.02482-14  0.09
2013 Shirazi F, Pontikos MA, Walsh TJ, Albert N, Lewis RE, Kontoyiannis DP. Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis. Antimicrobial Agents and Chemotherapy. 57: 4360-8. PMID 23817366 DOI: 10.1128/AAC.00571-13  0.089
2006 Pelletier R, Alarie I, Lagacé R, Walsh TJ. Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature. Medical Mycology. 43: 559-64. PMID 16320498 DOI: 10.1080/13693780500220415  0.089
2016 McCarthy MW, Walsh TJ. Molecular diagnosis of invasive mycoses of the central nervous system. Expert Review of Molecular Diagnostics. PMID 27936983 DOI: 10.1080/14737159.2017.1271716  0.089
2012 Walsh TJ, Bloom BE, Kontoyiannis DP. Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S1-4. PMID 22247440 DOI: 10.1093/cid/cir862  0.089
2007 Yang G, Walsh TJ, Shefi S, Turek PJ. The kinetics of the return of motile sperm to the ejaculate after vasectomy reversal. The Journal of Urology. 177: 2272-6. PMID 17509339 DOI: 10.1016/j.juro.2007.01.158  0.088
2013 Moriyama B, Jarosinski PF, Figg WD, Henning SA, Danner RL, Penzak SR, Wayne AS, Walsh TJ. Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype. Pharmacotherapy. 33: e19-22. PMID 23400848 DOI: 10.1002/Phar.1192  0.088
2017 McCarthy MW, Walsh TJ. Drug development challenges and strategies to address emerging and resistant fungal pathogens. Expert Review of Anti-Infective Therapy. PMID 28480775 DOI: 10.1080/14787210.2017.1328279  0.087
2006 Groll AH, Stergiopoulou T, Roilides E, Walsh TJ. Micafungin: pharmacology, experimental therapeutics and clinical applications. Expert Opinion On Investigational Drugs. 14: 489-509. PMID 15882123 DOI: 10.1517/13543784.14.4.489  0.087
2022 Petrou A, Zagaliotis P, Theodoroula NF, Mystridis GA, Vizirianakis IS, Walsh TJ, Geronikaki A. Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2. Molecules (Basel, Switzerland). 27. PMID 35408577 DOI: 10.3390/molecules27072180  0.087
2003 Gil-Lamaignere C, Roilides E, Lyman CA, Simitsopoulou M, Stergiopoulou T, Maloukou A, Walsh TJ. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury. Infection and Immunity. 71: 6472-8. PMID 14573669 DOI: 10.1128/IAI.71.11.6472-6478.2003  0.087
2019 John J, Loo A, Mazur S, Walsh TJ. Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients. Expert Opinion On Drug Metabolism & Toxicology. PMID 31550939 DOI: 10.1080/17425255.2019.1671971  0.087
2015 Moriyama B, Kadri S, Henning SA, Danner RL, Walsh TJ, Penzak SR. Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole. Current Fungal Infection Reports. 9: 74-87. PMID 26918067 DOI: 10.1007/s12281-015-0219-0  0.086
2013 Kanji JN, Laverdière M, Rotstein C, Walsh TJ, Shah PS, Haider S. Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials. Leukemia & Lymphoma. 54: 1479-87. PMID 23113686 DOI: 10.3109/10428194.2012.745073  0.086
2011 Reboli AC, Shorr AF, Rotstein C, Pappas PG, Kett DH, Schlamm HT, Reisman AL, Biswas P, Walsh TJ. Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. Bmc Infectious Diseases. 11: 261. PMID 21961941 DOI: 10.1186/1471-2334-11-261  0.086
2021 Arrieta AC, Neely M, Day JC, Rheingold SR, Sue PK, Muller WJ, Danziger-Isakov LA, Chu J, Yildirim I, McComsey GA, Frangoul HA, Chen TK, Statler VA, Steinbach WJ, Yin DE, ... ... Walsh TJ, et al. Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients. Antimicrobial Agents and Chemotherapy. PMID 34031051 DOI: 10.1128/AAC.00290-21  0.086
2014 Zhao Y, Armeanu E, DiVerniero R, Lewis TA, Dobson RC, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DS. Fungal DNA detected in blood samples of patients who received contaminated methylprednisolone injections reveals increased complexity of causative agents. Journal of Clinical Microbiology. 52: 2212-5. PMID 24719442 DOI: 10.1128/JCM.00854-14  0.086
2007 Meletiadis J, Stergiopoulou T, O'Shaughnessy EM, Peter J, Walsh TJ. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model. Antimicrobial Agents and Chemotherapy. 51: 2053-64. PMID 17387150 DOI: 10.1128/AAC.00873-06  0.085
2017 McCarthy MW, Aguilar-Zapata D, Petraitis V, Walsh TJ. Diagnosis, Classification, and Therapeutic Interventions for Sinopulmonary Aspergillosis. Expert Review of Respiratory Medicine. PMID 28095078 DOI: 10.1080/17476348.2017.1283986  0.085
2006 Antachopoulos C, Meletiadis J, Roilides E, Sein T, Walsh TJ. Rapid susceptibility testing of medically important zygomycetes by XTT assay. Journal of Clinical Microbiology. 44: 553-60. PMID 16455912 DOI: 10.1128/JCM.44.2.553-560.2006  0.085
2003 Bennett JE, Kauffman C, Walsh T, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Lee J, Pappas P, Powers J, Rex J, Verweij P, Viscoli C. Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: S123-7. PMID 12679896 DOI: 10.1086/367840  0.085
2006 Meletiadis J, Petraitis V, Petraitiene R, Lin P, Stergiopoulou T, Kelaher AM, Sein T, Schaufele RL, Bacher J, Walsh TJ. Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation. The Journal of Infectious Diseases. 194: 1008-18. PMID 16960790 DOI: 10.1086/506617  0.084
2015 Taj-Aldeen SJ, Rammaert B, Gamaletsou M, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Miller AO, Petraitis V, Walsh TJ, Lortholary O. Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review. Medicine. 94: e2078. PMID 26683917 DOI: 10.1097/MD.0000000000002078  0.084
2006 Dotis J, Simitsopoulou M, Dalakiouridou M, Konstantinou T, Taparkou A, Kanakoudi-Tsakalidou F, Walsh TJ, Roilides E. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 50: 868-73. PMID 16495244 DOI: 10.1128/AAC.50.3.868-873.2006  0.084
2007 Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ. Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species. Antimicrobial Agents and Chemotherapy. 51: 881-7. PMID 17145783 DOI: 10.1128/AAC.01160-06  0.084
2007 Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller MA, Rinaldi MG, Schell W, Walsh TJ. Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. Journal of Clinical Microbiology. 45: 2180-2. PMID 17475760 DOI: 10.1128/JCM.00399-07  0.083
2002 Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate. Antimicrobial Agents and Chemotherapy. 46: 834-40. PMID 11850269 DOI: 10.1128/AAC.46.3.834-840.2002  0.083
2019 Armellino D, Walsh TJ, Petraitis V, Kowalski W. Assessing the Feasibility of a Focused Multivector Ultraviolet System Between Surgery Cases with a Parallel Protocol for Enhanced Disinfection Capabilities. American Journal of Infection Control. PMID 30904373 DOI: 10.1016/J.Ajic.2019.02.017  0.083
2010 Demchok JP, Meletiadis J, Roilides E, Walsh TJ. Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp. Mycoses. 53: 239-45. PMID 19389068 DOI: 10.1111/j.1439-0507.2009.01700.x  0.083
2017 McCarthy MW, Walsh TJ. Drugs currently under investigation for the treatment of invasive candidiasis. Expert Opinion On Investigational Drugs. PMID 28617137 DOI: 10.1080/13543784.2017.1341488  0.083
2017 Satlin MJ, Walsh TJ. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients. Transplant Infectious Disease : An Official Journal of the Transplantation Society. PMID 28815897 DOI: 10.1111/tid.12762  0.082
2010 Lestner JM, Howard SJ, Goodwin J, Gregson L, Majithiya J, Walsh TJ, Jensen GM, Hope WW. Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy. 54: 3432-41. PMID 20439615 DOI: 10.1128/AAC.01586-09  0.082
2016 Hope WW, Walsh TJ, Goodwin J, Peloquin CA, Howard A, Kurtzberg J, Mendizabal A, Confer DL, Bulitta J, Baden LR, Neely MN, Wingard JR. Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial. The Journal of Antimicrobial Chemotherapy. PMID 27121401 DOI: 10.1093/jac/dkw127  0.082
2022 Catalano A, Iacopetta D, Ceramella J, Maio AC, Basile G, Giuzio F, Bonomo MG, Aquaro S, Walsh TJ, Sinicropi MS, Saturnino C, Geronikaki A, Salzano G. Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment? Foods (Basel, Switzerland). 11. PMID 36141012 DOI: 10.3390/foods11182884  0.082
2009 Spellberg B, Andes D, Perez M, Anglim A, Bonilla H, Mathisen GE, Walsh TJ, Ibrahim AS. Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrobial Agents and Chemotherapy. 53: 3122-5. PMID 19433555 DOI: 10.1128/Aac.00361-09  0.081
2008 Simitsopoulou M, Roilides E, Maloukou A, Gil-Lamaignere C, Walsh TJ. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes. Mycoses. 51: 147-54. PMID 18254752 DOI: 10.1111/j.1439-0507.2007.01457.x  0.081
2014 Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 20: 74-81. PMID 24279587 DOI: 10.1111/1469-0691.12466  0.081
2009 Moriyama B, Elinoff J, Danner RL, Gea-Banacloche J, Pennick G, Rinaldi MG, Walsh TJ. Accelerated metabolism of voriconazole and its partial reversal by cimetidine. Antimicrobial Agents and Chemotherapy. 53: 1712-4. PMID 19171800 DOI: 10.1128/AAC.01221-08  0.081
2002 Feld R, Paesmans M, Freifeld AG, Klastersky J, Pizzo PA, Rolston KV, Rubenstein E, Talcott JA, Walsh TJ. Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 35: 1463-8. PMID 12471564 DOI: 10.1086/344650  0.081
2010 Shoham S, Magill SS, Merz WG, Gonzalez C, Seibel N, Buchanan WL, Knudsen TA, Sarkisova TA, Walsh TJ. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Medical Mycology. 48: 511-7. PMID 19824881 DOI: 10.3109/13693780903311944  0.081
2020 Petraitiene R, Petraitis V, Maung BBW, Mansbach RS, Hodges MR, Finkelman MA, Shaw KJ, Walsh TJ. Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Endophthalmitis and Hematogenous Meningoencephalitis in Non-neutropenic Rabbits. Antimicrobial Agents and Chemotherapy. PMID 33361304 DOI: 10.1128/AAC.01795-20  0.081
2008 Smith JF, Walsh TJ, Lue TF. Peyronie's disease: a critical appraisal of current diagnosis and treatment. International Journal of Impotence Research. 20: 445-59. PMID 18650828 DOI: 10.1038/ijir.2008.30  0.081
2006 La Via WV, Lambert JL, Pelletier MJ, Morookian JM, Sirk SJ, Mickiene D, Walsh TJ, Borchert MS. Measurement of amphotericin B concentration by resonant Raman spectroscopy--a novel technique that may be useful for non-invasive monitoring. Medical Mycology. 44: 169-74. PMID 16519020 DOI: 10.1080/13693780500338761  0.08
2006 Groll AH, Walsh TJ. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections. Mycoses. 49: 7-16. PMID 16961576 DOI: 10.1111/j.1439-0507.2006.01296.x  0.08
2015 Walsh TJ, Azie N, Andes DR. Development of New Strategies for Echinocandins: Progress in Translational Research. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: S601-3. PMID 26567276 DOI: 10.1093/Cid/Civ676  0.08
2018 McCarthy MW, Katragkou A, Iosifidis E, Roilides E, Walsh TJ. Recent Advances in the Treatment of Scedosporiosis and Fusariosis. Journal of Fungi (Basel, Switzerland). 4. PMID 29912161 DOI: 10.3390/jof4020073  0.08
2011 Vethanayagam RR, Almyroudis NG, Grimm MJ, Lewandowski DC, Pham CT, Blackwell TS, Petraitiene R, Petraitis V, Walsh TJ, Urban CF, Segal BH. Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense. Plos One. 6: e28149. PMID 22163282 DOI: 10.1371/Journal.Pone.0028149  0.08
2022 Angulo DA, Alexander B, Rautemaa-Richardson R, Alastruey-Izquierdo A, Hoenigl M, Ibrahim AS, Ghannoum MA, King TR, Azie NE, Walsh TJ. Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections. Journal of Fungi (Basel, Switzerland). 8. PMID 36354888 DOI: 10.3390/jof8111121  0.08
2007 Hope WW, Shoham S, Walsh TJ. The pharmacology and clinical use of caspofungin. Expert Opinion On Drug Metabolism & Toxicology. 3: 263-74. PMID 17428155 DOI: 10.1517/17425255.3.2.263  0.079
2018 McCarthy MW, Moriyama B, Petraitiene R, Walsh TJ, Petraitis V. Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole. Clinical Pharmacokinetics. PMID 29725999 DOI: 10.1007/s40262-018-0673-2  0.079
2016 Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Henry M, Petraitis V, Denning DW, Lortholary O, Walsh TJ. Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases. Medical Mycology. PMID 27609563 DOI: 10.1093/mmy/myw077  0.079
2009 Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. Host immune response against Scedosporium species. Medical Mycology. 47: 433-40. PMID 19184770 DOI: 10.1080/13693780902738006  0.078
2010 Dornbusch HJ, Groll A, Walsh TJ. Diagnosis of invasive fungal infections in immunocompromised children. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 16: 1328-34. PMID 20678175 DOI: 10.1111/j.1469-0691.2010.03336.x  0.078
2008 Simitsopoulou M, Roilides E, Paliogianni F, Likartsis C, Ioannidis J, Kanellou K, Walsh TJ. Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors. Antimicrobial Agents and Chemotherapy. 52: 3301-6. PMID 18625774 DOI: 10.1128/AAC.01018-07  0.078
2013 Lewis RE, Ben-Ami R, Best L, Albert N, Walsh TJ, Kontoyiannis DP. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. The Journal of Infectious Diseases. 207: 834-41. PMID 23242544 DOI: 10.1093/infdis/jis767  0.078
2007 Hope WW, Seibel NL, Schwartz CL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ. Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. Antimicrobial Agents and Chemotherapy. 51: 3714-9. PMID 17638696 DOI: 10.1128/AAC.00398-07  0.077
2016 Chen TK, Groncy PK, Javahery R, Chai RY, Nagpala P, Finkelman M, Petraitiene R, Walsh TJ. Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1→3)-β-D-glucan. Medical Mycology. PMID 27838641 DOI: 10.1093/mmy/myw118  0.077
2022 Walsh TJ, Bright RA, Ahuja A, McCarthy MW, Marfuggi RA, Simpson SQ. Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms. Open Forum Infectious Diseases. 10: ofac645. PMID 36686626 DOI: 10.1093/ofid/ofac645  0.077
2023 Yasinskaya Y, Bala S, Waack U, Dixon C, Higgins K, Moore JN, Jjingo CJ, O'Shaughnessy E, Colangelo P, Botgros R, Nambiar S, Angulo D, Dane A, Chiller T, Hodges MR, ... ... Walsh TJ, et al. Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37021650 DOI: 10.1093/cid/ciad195  0.077
2010 Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Severino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 29: 1387-94. PMID 20703506 DOI: 10.1007/s10096-010-1013-0  0.077
2013 Satlin MJ, Calfee DP, Chen L, Fauntleroy KA, Wilson SJ, Jenkins SG, Feldman EJ, Roboz GJ, Shore TB, Helfgott DC, Soave R, Kreiswirth BN, Walsh TJ. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leukemia & Lymphoma. 54: 799-806. PMID 22916826 DOI: 10.3109/10428194.2012.723210  0.077
2018 Simitsopoulou M, Chlichlia K, Kyrpitzi D, Walsh TJ, Roilides E. Pharmacodynamic and immunomodulatory effects of micafungin on host responses against biofilms of in comparison to those of . Antimicrobial Agents and Chemotherapy. PMID 29866877 DOI: 10.1128/AAC.00478-18  0.076
2008 Meletiadis J, Chanock S, Walsh TJ. Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents. Pharmacogenomics. 9: 561-84. PMID 18466103 DOI: 10.2217/14622416.9.5.561  0.076
2005 Gil-Lamaignere C, Winn RM, Simitsopoulou M, Maloukou A, Walsh TJ, Roilides E. Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp. Medical Mycology. 43: 253-60. PMID 16010852 DOI: 10.1080/13693780412331271072  0.076
2005 Groll AH, Mickiene D, Petraitis V, Petraitiene R, Kelaher A, Sarafandi A, Wuerthwein G, Bacher J, Walsh TJ. Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits. The Journal of Antimicrobial Chemotherapy. 56: 899-907. PMID 16172108 DOI: 10.1093/JAC/DKI287  0.076
2006 Meletiadis J, Chanock S, Walsh TJ. Human pharmacogenomic variations and their implications for antifungal efficacy. Clinical Microbiology Reviews. 19: 763-87. PMID 17041143 DOI: 10.1128/CMR.00059-05  0.076
2012 Gamaletsou MN, Sipsas NV, Roilides E, Walsh TJ. Rhino-orbital-cerebral mucormycosis. Current Infectious Disease Reports. 14: 423-34. PMID 22684277 DOI: 10.1007/s11908-012-0272-6  0.076
2014 Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, Groll A, Lortholary O, Kontoyiannis DP, Petrikkos G. Development of new strategies for early diagnosis of mucormycosis from bench to bedside. Mycoses. 57: 2-7. PMID 25475924 DOI: 10.1111/myc.12249  0.076
2016 Katragkou A, Williams M, Sternberg S, Pantazatos D, Roilides E, Walsh TJ. Micafungin alters the amino acid, nucleic acid and central carbon metabolism of Candida albicans at subinhibitory concentrations: novel insights into mechanisms of action. The Journal of Antimicrobial Chemotherapy. PMID 28039272 DOI: 10.1093/jac/dkw478  0.075
2008 Ostrosky-Zeichner L, Rex JH, Pfaller MA, Diekema DJ, Alexander BD, Andes D, Brown SD, Chaturvedi V, Ghannoum MA, Knapp CC, Sheehan DJ, Walsh TJ. Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrobial Agents and Chemotherapy. 52: 4175-7. PMID 18809944 DOI: 10.1128/Aac.00420-08  0.075
2020 Byrne JM, Waack U, Weinstein EA, Joshi A, Shurland SM, Iarikov D, Bulitta JB, Diep BA, Guina T, Hope WW, Lawrenz MB, Lepak AJ, Luna BM, Miesel L, Phipps AJ, ... Walsh TJ, et al. FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development. Antimicrobial Agents and Chemotherapy. PMID 33106262 DOI: 10.1128/AAC.01983-20  0.075
2014 Zhao Y, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DS. Reply to "not over yet: fungal infections following methyl prednisolone injections smoulder on". Journal of Clinical Microbiology. 52: 3508. PMID 25143421 DOI: 10.1128/JCM.01745-14  0.075
2014 Grande RC, Walsh TJ, How JP. Sample efficient reinforcement learning with Gaussian processes 31st International Conference On Machine Learning, Icml 2014. 4: 3136-3150.  0.075
2015 Katragkou A, Roilides E, Walsh TJ. Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: S622-9. PMID 26567280 DOI: 10.1093/cid/civ746  0.075
2021 Jacobs SE, Zagaliotis P, Walsh TJ. Novel antifungal agents in clinical trials. F1000research. 10: 507. PMID 35136573 DOI: 10.12688/f1000research.28327.2  0.075
2018 Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, et al. Global Guidelines and Initiatives from the European Confederation of Medical Mycology to improve Patient Care and Research Worldwide: New Leadership is about Working Together. Mycoses. PMID 30086186 DOI: 10.1111/myc.12836  0.075
2007 Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ, Wingard JR. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: 402-9. PMID 17205448 DOI: 10.1086/510677  0.075
2018 McCarthy MW, Walsh TJ. Galactomannan antigenemia as a biomarker for therapeutic response of invasive aspergillosis: implications for clinical trial design and patient care. Expert Review of Molecular Diagnostics. PMID 29897826 DOI: 10.1080/14737159.2018.1488589  0.075
2021 Satlin MJ, Chen L, Douglass C, Hovan M, Davidson E, Soave R, La Spina M, Gomez-Arteaga A, van Besien K, Mayer S, Phillips A, Hsu JM, Malherbe R, Small CB, Jenkins SG, ... ... Walsh TJ, et al. Colonization with Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33956965 DOI: 10.1093/cid/ciab404  0.074
2004 Steinbach WJ, Benjamin DK, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 192-8. PMID 15307028 DOI: 10.1086/421950  0.074
2021 Huang YH, Magleby R, Rao R, Walsh TJ, Singh HK. Histoplasmosis in an off-trail Hiker receiving ustekinumab: Implications for Preventive and diagnostic strategies for patients receiving anti-IL-12/23 therapy. Medical Mycology Case Reports. 32: 43-46. PMID 33816098 DOI: 10.1016/j.mmcr.2021.03.004  0.074
2010 Hope WW, Petraitis V, Petraitiene R, Aghamolla T, Bacher J, Walsh TJ. The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy. Antimicrobial Agents and Chemotherapy. 54: 4879-86. PMID 20713673 DOI: 10.1128/AAC.00673-10  0.074
2008 Chamilos G, Lewis RE, Lamaris G, Walsh TJ, Kontoyiannis DP. Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrobial Agents and Chemotherapy. 52: 722-4. PMID 18025115 DOI: 10.1128/AAC.01136-07  0.074
2006 Steinbach WJ, Walsh TJ. Mycoses in pediatric patients. Infectious Disease Clinics of North America. 20: 663-78. PMID 16984874 DOI: 10.1016/j.idc.2006.06.006  0.074
2017 McCarthy MW, Walsh TJ. Containment strategies to address the expanding threat of multidrug-resistant Candida auris. Expert Review of Anti-Infective Therapy. PMID 29110544 DOI: 10.1080/14787210.2017.1402678  0.074
2011 Moriyama B, Ditullio M, Wilson E, Henning SA, Penzak SR, Danner RL, Pennick G, Rinaldi MG, Zelazny AM, Gea-Banacloche J, Barrett AJ, Walsh TJ. Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema. Antimicrobial Agents and Chemotherapy. 55: 2478-80. PMID 21402857 DOI: 10.1128/AAC.01560-10  0.074
2019 Redell M, Sierra-Hoffman M, Assi M, Bochan M, Chansolme D, Gandhi A, Sheridan K, Soosaipillai I, Walsh T, Massey J. The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections. Open Forum Infectious Diseases. 6: ofz479. PMID 31844635 DOI: 10.1093/ofid/ofz479  0.074
2017 McCarthy MW, Petraitis V, Walsh TJ. Combination Therapy for the Treatment of Pulmonary Mold Infections. Expert Review of Respiratory Medicine. PMID 28467730 DOI: 10.1080/17476348.2017.1325322  0.073
2010 Moriyama B, Henning SA, Childs R, Holland SM, Anderson VL, Morris JC, Wilson WH, Drusano GL, Walsh TJ. High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients. The Annals of Pharmacotherapy. 44: 929-35. PMID 20371747 DOI: 10.1345/Aph.1M717  0.073
2003 Benjamin DK, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-analytic Techniques Pediatrics. 112: 634-640. PMID 12949295 DOI: 10.1542/Peds.112.3.634  0.073
2010 Moriyama B, Torabi-Parizi P, Pratt AK, Henning SA, Pennick G, Shea YR, Roy Chowdhuri S, Rinaldi MG, Barrett AJ, Walsh TJ. Pharmacokinetics of liposomal amphotericin B in pleural fluid. Antimicrobial Agents and Chemotherapy. 54: 1633-5. PMID 20086161 DOI: 10.1128/AAC.01438-09  0.073
2015 Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. The Journal of Antimicrobial Chemotherapy. 70: 470-8. PMID 25288679 DOI: 10.1093/jac/dku374  0.073
2006 Almyroudis NG, Kontoyiannis DP, Sepkowitz KA, DePauw BE, Walsh TJ, Segal BH. Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 1449-55. PMID 17083020 DOI: 10.1086/508455  0.073
2016 Shaikh N, Hussain KA, Petraitiene R, Schuetz AN, Walsh TJ. Entomophthoramycosis: A Neglected Tropical Mycosis. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 27109491 DOI: 10.1016/j.cmi.2016.04.005  0.072
2003 Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. The Journal of Infectious Diseases. 188: 305-19. PMID 12854088 DOI: 10.1086/377210  0.072
2008 Prasad PA, Coffin SE, Leckerman KH, Walsh TJ, Zaoutis TE. Pediatric antifungal utilization: new drugs, new trends. The Pediatric Infectious Disease Journal. 27: 1083-8. PMID 18989239 DOI: 10.1097/INF.0b013e31817eeee5  0.072
2008 Hope WW, Mickiene D, Petraitis V, Petraitiene R, Kelaher AM, Hughes JE, Cotton MP, Bacher J, Keirns JJ, Buell D, Heresi G, Benjamin DK, Groll AH, Drusano GL, Walsh TJ. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. The Journal of Infectious Diseases. 197: 163-71. PMID 18171300 DOI: 10.1086/524063  0.072
2023 Jjingo CJ, Bala S, Waack U, Needles M, Bensman TJ, McMaster O, Smith T, Blakely B, Chan IZ, Puthawala K, Dixon C, Kim Y, Lim R, Colangelo P, St Clair C, ... ... Walsh TJ, et al. FDA Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37802928 DOI: 10.1093/cid/ciad607  0.072
2014 Katragkou A, McCarthy M, Meletiadis J, Petraitis V, Moradi PW, Strauss GE, Fouant MM, Kovanda LL, Petraitiene R, Roilides E, Walsh TJ. In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds. Antimicrobial Agents and Chemotherapy. 58: 6934-7. PMID 25136021 DOI: 10.1128/AAC.03261-14  0.072
2006 Roilides E, Lyman CA, Armstrong D, Stergiopoulou T, Petraitiene R, Walsh TJ. Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani. Mycoses. 49: 109-13. PMID 16466443 DOI: 10.1111/j.1439-0507.2006.01202.x  0.072
2017 Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, ... ... Walsh TJ, et al. Bacteremia due to Carbapenem-resistant Enterobacteriaceae (CRE): A Multicenter Clinical and Molecular Epidemiologic Analysis in the Nation's Epicenter for CRE. Antimicrobial Agents and Chemotherapy. PMID 28167547 DOI: 10.1128/Aac.02349-16  0.072
2017 McCarthy MW, Walsh TJ. Special Considerations for the Diagnosis and Treatment of Invasive Pulmonary Aspergillosis. Expert Review of Respiratory Medicine. PMID 28595486 DOI: 10.1080/17476348.2017.1340835  0.072
2018 Ostrowski KA, Holt SK, Haynes B, Davies BJ, Fuchs EF, Walsh TJ. Evaluation of Vasectomy Trends in the United States. Urology. PMID 29578040 DOI: 10.1016/j.urology.2018.03.016  0.072
2006 Panicker J, Walsh T, Kamani N. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. The Pediatric Infectious Disease Journal. 25: 377-9. PMID 16567998 DOI: 10.1097/01.inf.0000207475.89745.51  0.072
2014 Rammaert B, Gamaletsou MN, Zeller V, Elie C, Prinapori R, Taj-Aldeen SJ, Roilides E, Kontoyiannis DP, Brause B, Sipsas NV, Walsh TJ, Lortholary O. Dimorphic fungal osteoarticular infections. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 33: 2131-40. PMID 24939620 DOI: 10.1007/s10096-014-2149-0  0.071
2014 Gamaletsou MN, Walsh TJ, Zaoutis T, Pagoni M, Kotsopoulou M, Voulgarelis M, Panayiotidis P, Vassilakopoulos T, Angelopoulou MK, Marangos M, Spyridonidis A, Kofteridis D, Pouli A, Sotiropoulos D, Matsouka P, et al. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 20: O50-7. PMID 23889746 DOI: 10.1111/1469-0691.12312  0.071
2020 Huh D, Tran KD, Straiko MMW, McCarthy MW, Loo AS, Walsh TJ, Sales CS. Efficacy of Amphotericin B in Corneal Preservation Media After Extended Frozen Storage. Cornea. PMID 32482961 DOI: 10.1097/Ico.0000000000002381  0.071
2018 McCarthy MW, Walsh TJ. Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets. International Journal of Molecular Sciences. 19. PMID 29562716 DOI: 10.3390/ijms19030909  0.071
2003 Bennett JE, Powers J, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Kauffman C, Lee J, Pappas P, Rex J, Verweij P, Viscoli C, Walsh T. Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: S113-6. PMID 12679894 DOI: 10.1086/367838  0.071
2017 Queiroz-Telles F, de Hoog S, Santos DW, Salgado CG, Vicente VA, Bonifaz A, Roilides E, Xi L, Azevedo CM, da Silva MB, Pana ZD, Colombo AL, Walsh TJ. Chromoblastomycosis. Clinical Microbiology Reviews. 30: 233-276. PMID 27856522 DOI: 10.1128/CMR.00032-16  0.071
2007 Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, ... ... Walsh TJ, et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. The Journal of Infectious Diseases. 195: 455-66. PMID 17205486 DOI: 10.1086/510535  0.071
2017 Zhao M, Bulman ZP, Lenhard JR, Satlin MJ, Kreiswirth BN, Walsh TJ, Marrocco A, Bergen PJ, Nation RL, Li J, Zhang J, Tsuji BT. Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae. The Journal of Antimicrobial Chemotherapy. PMID 28444224 DOI: 10.1093/Jac/Dkx070  0.071
2007 Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. European Journal of Pediatrics. 166: 1099-117. PMID 17551753 DOI: 10.1007/s00431-007-0527-7  0.071
2007 Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts R, Wible M, Goldstein BP, Schranz J, Krause DS, Walsh TJ. Anidulafungin versus fluconazole for invasive candidiasis. The New England Journal of Medicine. 356: 2472-82. PMID 17568028 DOI: 10.1056/Nejmoa066906  0.07
2013 Jacobs SE, Lamson DM, St George K, Walsh TJ. Human rhinoviruses. Clinical Microbiology Reviews. 26: 135-62. PMID 23297263 DOI: 10.1128/CMR.00077-12  0.07
2008 Smith PB, Garges HP, Cotton CM, Walsh TJ, Clark RH, Benjamin DK. Meningitis in preterm neonates: importance of cerebrospinal fluid parameters. American Journal of Perinatology. 25: 421-6. PMID 18726835 DOI: 10.1055/s-0028-1083839  0.07
2018 Kovanda LL, Walsh TJ, Benjamin DK, Arrieta A, Kaufman DA, Smith PB, Manzoni P, Desai AV, Kaibara A, Bonate PL, Hope WW. Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials. The Pediatric Infectious Disease Journal. 37: 580-585. PMID 29762386 DOI: 10.1097/INF.0000000000001957  0.07
2011 Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, et al. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial Agents and Chemotherapy. 55: 1543-8. PMID 21282457 DOI: 10.1128/Aac.01510-09  0.07
2014 Katragkou A, Pana ZD, Perlin DS, Kontoyiannis DP, Walsh TJ, Roilides E. Exserohilum infections: review of 48 cases before the 2012 United States outbreak. Medical Mycology. 52: 376-86. PMID 24682112 DOI: 10.1093/mmy/myt030  0.07
2011 Green DT, Walsh TJ, Cohen PR, Chang YH. Learning a skill-teaching curriculum with dynamic bayes nets Proceedings of the National Conference On Artificial Intelligence. 2: 1648-1654.  0.07
2011 Yaman F, Walsh TJ, Littman ML, Desjardins M. Learning lexicographic preference models Preference Learning. 251-272. DOI: 10.1007/978-3-642-14125-6_12  0.07
2000 Walsh TJ, Jackson AJ, Lee JW, Amantea M, Sein T, Bacher J, Zech L. Dose-Dependent Pharmacokinetics of Amphotericin B Lipid Complex in Rabbits Antimicrobial Agents and Chemotherapy. 44: 2924-2924. DOI: 10.1128/Aac.44.10.2924-2924.2000  0.07
2005 Antachopoulos C, Walsh TJ. New agents for invasive mycoses in children Current Opinion in Pediatrics. 17: 78-87. PMID 15659969 DOI: 10.1097/01.mop.0000150630.83442.e1  0.069
2013 Such KA, Petraitis V, Petraitiene R, Strauss GE, Moradi PW, Walsh TJ. Environmental monitoring for Aspergillus fumigatus in association with an immunosuppressed rabbit model of pulmonary aspergillosis. Journal of the American Association For Laboratory Animal Science : Jaalas. 52: 541-4. PMID 24041208  0.069
2009 Walsh TJ, Petraitis V, Petraitiene R, Solomon J, Bacher JD, Greene L, Cotton M, Groll A, Roilides E, Avila N, Pyrgos V, Shoham S. Diagnostic imaging of experimental invasive pulmonary aspergillosis. Medical Mycology. 47: S138-45. PMID 19253145 DOI: 10.1080/13693780802665879  0.069
2005 Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. The Journal of Infectious Diseases. 191: 1180-7. PMID 15747255 DOI: 10.1086/428503  0.069
2006 Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. Journal of Clinical Microbiology. 44: 819-26. PMID 16517860 DOI: 10.1128/Jcm.44.3.819-826.2006  0.068
2011 Walsh TJ, Wissel MC, Grantham KJ, Petraitiene R, Petraitis V, Kasai M, Francesconi A, Cotton MP, Hughes JE, Greene L, Bacher JD, Manna P, Salomoni M, Kleiboeker SB, Reddy SK. Molecular detection and species-specific identification of medically important Aspergillus species by real-time PCR in experimental invasive pulmonary aspergillosis. Journal of Clinical Microbiology. 49: 4150-7. PMID 21976757 DOI: 10.1128/Jcm.00570-11  0.068
2012 Lewis RE, Lortholary O, Spellberg B, Roilides E, Kontoyiannis DP, Walsh TJ. How does antifungal pharmacology differ for mucormycosis versus aspergillosis? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S67-72. PMID 22247448 DOI: 10.1093/cid/cir884  0.068
2011 Simitsopoulou M, Roilides E, Georgiadou E, Paliogianni F, Walsh TJ. Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus. Medical Mycology. 49: 176-85. PMID 20807031 DOI: 10.3109/13693786.2010.510539  0.068
2009 Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Balajee SA, Pappas PG, Moser SA. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. Journal of Clinical Microbiology. 47: 3271-5. PMID 19692558 DOI: 10.1128/Jcm.00854-09  0.068
2010 Pyrgos V, Mickiene D, Sein T, Cotton M, Fransesconi A, Mizrahi I, Donoghue M, Bundrant N, Kim SY, Hardwick M, Shoham S, Walsh TJ. Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole. Antimicrobial Agents and Chemotherapy. 54: 1305-10. PMID 19995929 DOI: 10.1128/AAC.01263-09  0.068
2016 Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Miller AO, Petraitiene R, Lortholary O, Walsh TJ. Candida Arthritis: Analysis of 112 Pediatric and Adult Cases. Open Forum Infectious Diseases. 3: ofv207. PMID 26858961 DOI: 10.1093/ofid/ofv207  0.068
2011 Walsh TJ, Hewlett D, Morrison CT. Blending autonomous exploration and apprenticeship learning Advances in Neural Information Processing Systems 24: 25th Annual Conference On Neural Information Processing Systems 2011, Nips 2011 0.068
2002 Groll AH, Walsh TJ. Antifungal chemotherapy: Advances and perspectives Swiss Medical Weekly. 132: 303-311. PMID 12362280  0.068
2022 Zagaliotis P, Michalik-Provasek J, Gill JJ, Walsh TJ. Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans. Pathogens & Immunity. 7: 1-45. PMID 36320594 DOI: 10.20411/pai.v7i2.516  0.068
2015 Bellanger AP, Albert ND, Lewis RE, Walsh TJ, Kontoyiannis DP. Effect of Pre-exposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae: A Complex Relationship. Antimicrobial Agents and Chemotherapy. PMID 26392499 DOI: 10.1128/AAC.01583-15  0.068
2023 Jacobs SE, Walsh TJ. Non- Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases. Journal of Fungi (Basel, Switzerland). 9. PMID 36836326 DOI: 10.3390/jof9020212  0.068
2015 Corzo-León DE, Satlin MJ, Soave R, Shore TB, Schuetz AN, Jacobs SE, Walsh TJ. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses. 58: 325-36. PMID 25808822 DOI: 10.1111/myc.12318  0.068
2023 Wurster S, García JP, Albert ND, Jiang Y, Bhoda K, Kulkarni VV, Wang Y, Walsh TJ, Evans S, Kontoyiannis DP. Development of a corticosteroid-immunosuppressed mouse model to study the pathogenesis and therapy of influenza-associated pulmonary aspergillosis. The Journal of Infectious Diseases. PMID 36611269 DOI: 10.1093/infdis/jiad001  0.068
2007 Chiou CC, Walsh TJ, Groll AH. Clinical pharmacology of antifungal agents in pediatric patients. Expert Opinion On Pharmacotherapy. 8: 2465-89. PMID 17931084 DOI: 10.1517/14656566.8.15.2465  0.068
2006 Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. American Journal of Respiratory and Critical Care Medicine. 173: 707-17. PMID 16387806 DOI: 10.1164/rccm.200505-727SO  0.067
2010 Aaronson DS, Iman R, Walsh TJ, Kurhanewicz J, Turek PJ. A novel application of 1H magnetic resonance spectroscopy: non-invasive identification of spermatogenesis in men with non-obstructive azoospermia. Human Reproduction (Oxford, England). 25: 847-52. PMID 20124393 DOI: 10.1093/Humrep/Dep475  0.067
2009 Roilides E, Zaoutis TE, Katragkou A, Benjamin DK, Walsh TJ. Zygomycosis in neonates: an uncommon but life-threatening infection. American Journal of Perinatology. 26: 565-73. PMID 19391079 DOI: 10.1055/s-0029-1220775  0.067
2015 Chatzimoschou A, Simitsopoulou M, Antachopoulos C, Walsh TJ, Roilides E. Differential effects of antifungal agents on expression of genes related to formation of Candida albicans biofilms. Mycoses. PMID 26593284 DOI: 10.1111/myc.12436  0.067
2016 Moriyama B, Obeng AO, Barbarino J, Penzak SR, Henning SA, Scott SA, Agúndez JA, Wingard JR, McLeod HL, Klein TE, Cross S, Caudle KE, Walsh TJ. Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy. Clinical Pharmacology and Therapeutics. PMID 27981572 DOI: 10.1002/Cpt.583  0.067
2008 Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, Brown SD, Chaturvedi V, Ghannoum MA, Knapp CC, Sheehan DJ, Walsh TJ. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. Journal of Clinical Microbiology. 46: 2620-9. PMID 18579718 DOI: 10.1128/Jcm.00566-08  0.067
2010 Simitsopoulou M, Georgiadou E, Walsh TJ, Roilides E. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp. Medical Mycology. 48: 720-4. PMID 20100138 DOI: 10.3109/13693780903476635  0.067
2016 Williams KM, Ahn KW, Chen M, Aljurf MD, Agwu AL, Chen AR, Walsh TJ, Szabolcs P, Boeckh MJ, Auletta JJ, Lindemans CA, Zanis-Neto J, Malvezzi M, Lister J, de Toledo Codina JS, et al. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis. Bone Marrow Transplantation. PMID 26726945 DOI: 10.1038/bmt.2015.316  0.067
2019 Mojica MF, Rutter JD, Taracila M, Abriata LA, Fouts DE, Papp-Wallace KM, Walsh TJ, LiPuma JJ, Vila AJ, Bonomo RA. Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States. Mbio. 10. PMID 31266860 DOI: 10.1128/Mbio.00405-19  0.067
2005 Choi EH, Taylor JG, Foster CB, Walsh TJ, Anttila VJ, Ruutu T, Palotie A, Chanock SJ. Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients. Medical Mycology. 43: 349-53. PMID 16110781 DOI: 10.1080/13693780412331282322  0.067
2020 Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR, Andes DR, Walsh TJ, Pappas PG, Cornely OA, Perfect JR, Kontoyiannis DP. Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. The Journal of Infectious Diseases. 222: S175-S198. PMID 32756879 DOI: 10.1093/Infdis/Jiaa394  0.067
2008 Chaturvedi V, Ramani R, Ghannoum MA, Killian SB, Holliday N, Knapp C, Ostrosky-Zeichner L, Messer SA, Pfaller MA, Iqbal NJ, Arthington-Skaggs BA, Vazquez JA, Sein T, Rex JH, Walsh TJ. Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei. Antimicrobial Agents and Chemotherapy. 52: 1500-2. PMID 18227180 DOI: 10.1128/AAC.00574-07  0.067
2015 Salvatore CM, Chen TK, Toussi SS, DeLaMora P, Petraitiene R, Finkelman MA, Walsh TJ. (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients. Journal of the Pediatric Infectious Diseases Society. PMID 26407252 DOI: 10.1093/jpids/piv014  0.066
2012 Shupp JW, Petraitiene R, Jaskille AD, Pavlovich AR, Matt SE, Nguyen do T, Kath MA, Jeng JC, Jordan MH, Finkelman M, Walsh TJ, Shoham S. Early serum (1→3)-β-D-glucan levels in patients with burn injury. Mycoses. 55: 224-7. PMID 21771107 DOI: 10.1111/j.1439-0507.2011.02068.x  0.066
2004 Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. The New England Journal of Medicine. 351: 1391-402. PMID 15459300 DOI: 10.1056/NEJMoa040446  0.066
2006 Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Archives of Internal Medicine. 166: 1863-70. PMID 17000943 DOI: 10.1001/Archinte.166.17.1863  0.066
2014 Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1274-83. PMID 24463280 DOI: 10.1093/cid/ciu052  0.066
2012 Anawalt BD, Hotaling JM, Walsh TJ, Matsumoto AM. Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism. The Journal of Urology. 187: 1369-73. PMID 22341266 DOI: 10.1016/j.juro.2011.11.095  0.066
2009 Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ. Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus. The Journal of Antimicrobial Chemotherapy. 63: 343-8. PMID 19109335 DOI: 10.1093/jac/dkn473  0.066
2019 Walsh TJ, Katragkou A, Chen T, Salvatore CM, Roilides E. Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment. Journal of Fungi (Basel, Switzerland). 5. PMID 30678324 DOI: 10.3390/jof5010011  0.066
2007 Stergiopoulou T, Meletiadis J, Roilides E, Kleiner DE, Schaufele R, Roden M, Harrington S, Dad L, Segal B, Walsh TJ. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. American Journal of Clinical Pathology. 127: 349-55. PMID 17276936 DOI: 10.1309/UJRV9DLC11RM3G8R  0.066
2006 Francesconi A, Kasai M, Petraitiene R, Petraitis V, Kelaher AM, Schaufele R, Hope WW, Shea YR, Bacher J, Walsh TJ. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. Journal of Clinical Microbiology. 44: 2475-80. PMID 16825367 DOI: 10.1128/JCM.02693-05  0.066
2019 Nguyen MH, Clancy CJ, Pasculle AW, Pappas PG, Alangaden G, Pankey GA, Schmitt BH, Rasool A, Weinstein MP, Widen R, Hernandez DR, Wolk DM, Walsh TJ, Perfect JR, Wilson MN, et al. Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study. Annals of Internal Medicine. PMID 31083728 DOI: 10.7326/M18-2772  0.065
2011 Hewlett D, Walsh TJ, Cohen P. Teaching and executing verb phrases 2011 Ieee International Conference On Development and Learning, Icdl 2011. DOI: 10.1109/DEVLRN.2011.6037340  0.065
2015 McCarty TP, Baddley JW, Walsh TJ, Alexander BD, Kontoyiannis DP, Perl TM, Walker R, Patterson TF, Schuster MG, Lyon GM, Wingard JR, Andes DR, Park BJ, Brandt ME, Pappas PG, et al. Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). Medical Mycology. 53: 440-6. PMID 25908651 DOI: 10.1093/Mmy/Myv018  0.065
2022 Gamaletsou MN, Rammaert B, Brause B, Bueno MA, Dadwal SS, Henry MW, Katragkou A, Kontoyiannis DP, McCarthy MW, Miller AO, Moriyama B, Pana ZD, Petraitiene R, Petraitis V, Roilides E, ... ... Walsh TJ, et al. Osteoarticular Mycoses. Clinical Microbiology Reviews. e0008619. PMID 36448782 DOI: 10.1128/cmr.00086-19  0.065
2008 Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ. Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 52: 2196-204. PMID 18299413 DOI: 10.1128/AAC.00735-07  0.065
2017 McCarthy MW, Walsh TJ. Prophylactic Measures During Induction for Acute Myeloid Leukemia. Current Oncology Reports. 19: 18. PMID 28251490 DOI: 10.1007/s11912-017-0574-9  0.065
2013 Loo AS, Muhsin SA, Walsh TJ. Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B. Expert Opinion On Drug Safety. 12: 881-95. PMID 23931455 DOI: 10.1517/14740338.2013.827168  0.065
2022 McVeigh TP, Sweeney KJ, Brennan DJ, McVeigh UM, Ward S, Strydom A, Seal S, Astbury K, Donnellan P, Higgins J, Keane M, Kerin MJ, Malone C, McGough P, McLaughlin R, ... ... Walsh T, et al. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland. Familial Cancer. PMID 36029389 DOI: 10.1007/s10689-022-00313-0  0.065
2015 Lee AP, Roth MY, Nya-Ngatchou JJ, Lin K, Walsh TJ, Page ST, Matsumoto AM, Bremner WJ, Amory JK, Anawalt BD. Testicular fine-needle aspiration for the assessment of intratesticular hormone concentrations. Asian Journal of Andrology. PMID 26208394 DOI: 10.4103/1008-682X.156637  0.065
2014 Cutler M, Walsh TJ, How JP. Reinforcement learning with multi-fidelity simulators Proceedings - Ieee International Conference On Robotics and Automation. 3888-3895. DOI: 10.1109/ICRA.2014.6907423  0.065
2011 Hewlett D, Walsh TJ, Cohen P. A framework for teaching and executing verb phrases Aaai Spring Symposium - Technical Report. 18-23.  0.065
2013 Petraitis V, Petraitiene R, Antachopoulos C, Hughes JE, Cotton MP, Kasai M, Harrington S, Gamaletsou MN, Bacher JD, Kontoyiannis DP, Roilides E, Walsh TJ. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism. Medical Mycology. 51: 72-82. PMID 22686246 DOI: 10.3109/13693786.2012.690107  0.065
2015 Hussain K, Walsh TJ, Chazen JL. Brain MRI findings with vigabatrin therapy: case report and literature review. Clinical Imaging. PMID 26526789 DOI: 10.1016/j.clinimag.2015.07.016  0.064
2023 Singh N, Eickhoff C, Garcia-Agundez A, Bertone P, Paudel SS, Tambe DT, Litzky LA, Cox-Flaherty K, Klinger JR, Monaghan SF, Mullin CJ, Pereira M, Walsh T, Whittenhall M, Stevens T, et al. Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension. Scientific Reports. 13: 22534. PMID 38110438 DOI: 10.1038/s41598-023-48077-6  0.064
2005 Peter J, Armstrong D, Lyman CA, Walsh TJ. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp. Journal of Clinical Microbiology. 43: 3788-92. PMID 16081911 DOI: 10.1128/JCM.43.8.3788-3792.2005  0.064
2010 Walsh T, Delahunt E, McCarthy Persson U. Effects of taping on thumb alignment and force application during PA mobilisations. Manual Therapy. 16: 264-9. PMID 21185223 DOI: 10.1016/j.math.2010.11.006  0.064
2024 Walsh TJ, Mencacci A, Paggi R, Douka E, Vrettou C, Smith R, Guzman O. Prospective observational pilot study of the T2Resistance panel in the T2Dx system for detection of resistance genes in bacterial bloodstream infections. Journal of Clinical Microbiology. e0129623. PMID 38456690 DOI: 10.1128/jcm.01296-23  0.064
2012 Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S16-22. PMID 22247441 DOI: 10.1093/cid/cir865  0.064
2018 Andes D, Kovanda L, Desai A, Kitt T, Zhao M, Walsh TJ. Isavuconazole Concentration in Real-world Practice: Consistency with Results from Clinical Trials. Antimicrobial Agents and Chemotherapy. PMID 29735569 DOI: 10.1128/Aac.00585-18  0.064
2013 Kontoyiannis DP, Perlin DS, Roilides E, Walsh TJ. What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 853-9. PMID 23650291 DOI: 10.1093/cid/cit283  0.064
2013 Simitsopoulou M, Peshkova P, Tasina E, Katragkou A, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates. Antimicrobial Agents and Chemotherapy. 57: 2562-70. PMID 23529739 DOI: 10.1128/AAC.02541-12  0.064
2020 Papachristou SG, Iosifidis E, Sipsas NV, Gamaletsou MN, Walsh TJ, Roilides E. Management of osteoarticular fungal infections in the setting of immunodeficiency. Expert Review of Anti-Infective Therapy. 1-14. PMID 32213145 DOI: 10.1080/14787210.2020.1748499  0.064
2006 Petraitis V, Petraitiene R, Solomon J, Kelaher AM, Murray HA, Mya-San C, Bhandary AK, Sein T, Avila NA, Basevicius A, Bacher J, Walsh TJ. Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy. 50: 1510-7. PMID 16569871 DOI: 10.1128/AAC.50.4.1510-1517.2006  0.064
2013 Geramifard A, Walsh TJ, Tellex S, Chowdhary G, Roy N, How JP. A tutorial on linear function approximators for dynamic programming and reinforcement learning Foundations and Trends in Machine Learning. 6: 375-454. DOI: 10.1561/2200000042  0.063
2022 Kowalski W, Moeller R, Walsh TJ, Petraitis V, Passman FJ. Ultraviolet disinfection efficacy test method using bacteria monolayers. Journal of Microbiological Methods. 200: 106541. PMID 35870538 DOI: 10.1016/j.mimet.2022.106541  0.063
2008 Wu AK, Walsh TJ, Phonsombat S, Croughan MS, Turek PJ. Bilateral but not unilateral testicular hypotrophy predicts for severe impairment of semen quality in men with varicocele undergoing infertility evaluation. Urology. 71: 1114-8. PMID 18538693 DOI: 10.1016/j.urology.2007.12.074  0.063
2019 Small KW, Tran EM, Garabetian CA, Avetisjan J, Walsh TJ, Shaya FS. Fungal Endophthalmitis after Intravitreal Injections of Triamcinolone Contaminated by a Compounding Pharmacy: Five-Year Follow-up of 23 Patients. Ophthalmology. Retina. 3: 133-139. PMID 31014761 DOI: 10.1016/j.oret.2018.09.009  0.063
2015 Satlin MJ, Vardhana S, Soave R, Shore TB, Mark TM, Jacobs SE, Walsh TJ, Gergis U. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26150022 DOI: 10.1016/j.bbmt.2015.06.017  0.063
2018 Downie ML, Alghounaim M, Davidge KM, Yau Y, Walsh TJ, Pope E, Somers GR, Waters V, Robinson LA. Isolated cutaneous mucormycosis in a pediatric renal transplant recipient. Pediatric Transplantation. e13172. PMID 29569805 DOI: 10.1111/petr.13172  0.063
2019 Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, ... ... Walsh TJ, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet. Infectious Diseases. PMID 31699664 DOI: 10.1016/S1473-3099(19)30312-3  0.063
2012 Lopushnyan NA, Walsh TJ. Surgical techniques for the management of male infertility. Asian Journal of Andrology. 14: 94-102. PMID 22120932 DOI: 10.1038/aja.2011.62  0.062
2022 Meletiadis J, Andes DR, Lockhart SR, Ghannoum MA, Knapp CC, Ostrosky-Zeichner L, Pfaller MA, Chaturvedi V, Walsh TJ. Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis. Journal of Fungi (Basel, Switzerland). 8. PMID 36135692 DOI: 10.3390/jof8090967  0.062
2008 Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, Kottilil S, Walsh TJ. Infections caused by Scedosporium spp. Clinical Microbiology Reviews. 21: 157-97. PMID 18202441 DOI: 10.1128/CMR.00039-07  0.062
2003 Groll AH, Gea-Banacloche JC, Glasmacher A, Just-Nuebling G, Maschmeyer G, Walsh TJ. Clinical pharmacology of antifungal compounds. Infectious Disease Clinics of North America. 17: 159-91, ix. PMID 12751265 DOI: 10.1016/S0891-5520(02)00068-5  0.062
2014 Walsh TJ, Hotaling JM, Smith A, Saigal C, Wessells H. Men with diabetes may require more aggressive treatment for erectile dysfunction. International Journal of Impotence Research. 26: 112-5. PMID 24352244 DOI: 10.1038/ijir.2013.46  0.062
2009 Hickey PW, Sutton DA, Fothergill AW, Rinaldi MG, Wickes BL, Schmidt HJ, Walsh TJ. Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis. Journal of Clinical Microbiology. 47: 3091-7. PMID 19656976 DOI: 10.1128/Jcm.00460-09  0.062
2013 Cooley SM, Donnelly JC, Walsh T, McMahon C, Gillan J, Geary MP. The correlation of ultrasonographic placental architecture with placental histology in the low-risk primigravid population Journal of Perinatal Medicine. 41: 505-509. PMID 23515100 DOI: 10.1515/jpm-2013-0015  0.062
2005 Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagnostic Microbiology and Infectious Disease. 52: 295-8. PMID 15922535 DOI: 10.1016/j.diagmicrobio.2005.03.002  0.062
2018 McCarthy MW, Walsh TJ. Candidemia in the cancer patient: diagnosis, treatment, and future directions. Expert Review of Anti-Infective Therapy. 1-6. PMID 30322269 DOI: 10.1080/14787210.2018.1536546  0.061
2011 Katragkou A, Simitsopoulou M, Chatzimoschou A, Georgiadou E, Walsh TJ, Roilides E. Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells. Cytokine. 55: 330-4. PMID 21641233 DOI: 10.1016/j.cyto.2011.05.007  0.061
2012 Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S55-60. PMID 22247446 DOI: 10.1093/cid/cir868  0.061
2003 Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: 1122-31. PMID 12715306 DOI: 10.1086/374557  0.061
2004 Steinbach WJ, Perfect JR, Schell WA, Walsh TJ, Benjamin DK. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrobial Agents and Chemotherapy. 48: 3217-25. PMID 15328076 DOI: 10.1128/AAC.48.9.3217-3225.2004  0.061
2007 Walsh TJ, Porter MP. Ureteroscopic treatment of upper-tract urothelial lesions: a novel technique. Journal of Endourology / Endourological Society. 21: 718-20. PMID 17705757 DOI: 10.1089/end.2006.0344  0.061
2009 Hatziagorou E, Walsh TJ, Tsanakas JN, Roilides E. Aspergillus and the paediatric lung. Paediatric Respiratory Reviews. 10: 178-85. PMID 19879507 DOI: 10.1016/J.Prrv.2009.06.006  0.061
2015 Bellanger AP, Minetos YD, Albert N, Shirazi F, Walsh TJ, Kontoyiannis DP. Glucocorticosteroids do not impact directly growth rate and biomass of Rhizopus arrhizus (syn. R. oryzae) in vitro. Virulence. 0. PMID 25942104 DOI: 10.1080/21505594.2015.1039762  0.06
2015 Walters HM, Pan N, Lehman TJ, Adams A, Huang WT, Sitaras L, Cunningham-Rundles S, Walsh TJ, Toussi SS. A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors. Clinical Rheumatology. 34: 457-64. PMID 25227771 DOI: 10.1007/s10067-014-2779-8  0.06
2021 Zhang SX, Babady NE, Hanson KE, Harrington AT, Larkin PMK, Leal SM, Luethy PM, Martin IW, Pancholi P, Procop GW, Riedel S, Seyedmousavi S, Sullivan KV, Walsh TJ, Lockhart SR, et al. Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC). Journal of Clinical Microbiology. PMID 33504591 DOI: 10.1128/JCM.01784-20  0.06
2017 McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ. Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi. The Journal of Infectious Diseases. 216: S474-S483. PMID 28911042 DOI: 10.1093/infdis/jix130  0.06
1997 Stackman RW, Bartolomeo AC, Walsh TJ. Vitamin E attenuates the effects of both reversible and irreversible inhibitors of high-affinity choline transport in vivo Restorative Neurology and Neuroscience. 11: 83-89.  0.06
2012 Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJ. Combination therapy for mucormycosis: why, what, and how? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S73-8. PMID 22247449 DOI: 10.1093/cid/cir885  0.06
2021 Chaekal OK, Soave R, Chen Z, Shore T, Mayer S, Phillips A, Mei Hsu J, Gomez-Arteaga A, Rennert H, Drelick A, Orfali N, Walsh TJ, Small CB, Kodiyanplakkal RPL, Plate M, et al. Adenovirus viremia after T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes. Leukemia & Lymphoma. 1-8. PMID 34643477 DOI: 10.1080/10428194.2021.1978088  0.06
2011 Pfaller MA, Andes D, Arendrup MC, Diekema DJ, Espinel-Ingroff A, Alexander BD, Brown SD, Chaturvedi V, Fowler CL, Ghannoum MA, Johnson EM, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Walsh TJ. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagnostic Microbiology and Infectious Disease. 70: 330-43. PMID 21546199 DOI: 10.1016/J.Diagmicrobio.2011.03.002  0.06
2012 Johnson MD, Plantinga TS, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LA, van der Meer JW, van Dissel JT, Walsh TJ, Perfect JR, et al. Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 502-10. PMID 22144535 DOI: 10.1093/Cid/Cir827  0.06
2003 Gil-Lamaignere C, Roilides E, Maloukou A, Georgopoulou I, Petrikkos G, Walsh TJ. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum. The Journal of Antimicrobial Chemotherapy. 50: 1027-30. PMID 12461027 DOI: 10.1093/JAC/DKF198  0.06
2019 McCarthy MW, Keyloun KR, Gillard P, Choi JJ, Pickell N, Copp R, Walsh TJ. Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial. Infectious Diseases and Therapy. PMID 31713130 DOI: 10.1007/s40121-019-00275-4  0.06
2004 Reddy BK, Brewster PS, Walsh T, Burket MW, Thomas WJ, Cooper CJ. Randomized comparison of rapid ambulation using radial, 4 French femoral access, or femoral access with AngioSeal closure Catheterization and Cardiovascular Interventions. 62: 143-149. PMID 15170701 DOI: 10.1002/ccd.20027  0.06
2008 De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1813-21. PMID 18462102 DOI: 10.1086/588660  0.06
2006 Ghannoum MA, Arthington-Skaggs B, Chaturvedi V, Espinel-Ingroff A, Pfaller MA, Rennie R, Rinaldi MG, Walsh TJ. Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals. Journal of Clinical Microbiology. 44: 4353-6. PMID 17050812 DOI: 10.1128/Jcm.00688-06  0.06
2017 Henry MW, Miller AO, Walsh TJ, Brause BD. Fungal Musculoskeletal Infections. Infectious Disease Clinics of North America. 31: 353-368. PMID 28483045 DOI: 10.1016/j.idc.2017.01.006  0.06
2003 Petraitis V, Petraitiene R, Sarafandi AA, Kelaher AM, Lyman CA, Casler HE, Sein T, Groll AH, Bacher J, Avila NA, Walsh TJ. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. The Journal of Infectious Diseases. 187: 1834-43. PMID 12792859 DOI: 10.1086/375420  0.059
2008 Kasai M, Harrington SM, Francesconi A, Petraitis V, Petraitiene R, Beveridge MG, Knudsen T, Milanovich J, Cotton MP, Hughes J, Schaufele RL, Sein T, Bacher J, Murray PR, Kontoyiannis DP, ... Walsh TJ, et al. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. Journal of Clinical Microbiology. 46: 3690-702. PMID 18845827 DOI: 10.1128/JCM.00917-08  0.059
2014 Amory JK, Arnold S, Lardone MC, Piottante A, Ebensperger M, Isoherranen N, Muller CH, Walsh T, Castro A. Levels of the retinoic acid synthesizing enzyme aldehyde dehydrogenase-1A2 are lower in testicular tissue from men with infertility. Fertility and Sterility. 101: 960-6. PMID 24524833 DOI: 10.1016/J.Fertnstert.2013.12.053  0.059
2005 Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 1684-8. PMID 15889369 DOI: 10.1086/430068  0.059
2005 Dignani MC, Rex JH, Chan KW, Dow G, deMagalhaes-Silverman M, Maddox A, Walsh T, Anaissie E. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia. Cancer. 104: 199-204. PMID 15929126 DOI: 10.1002/cncr.21142  0.059
2011 Lavine SJ, Walsh T. Exercise Tolerance and the Post Exercise Diastolic Filling Pattern in Patients With the Resting Impaired Relaxation. Cardiology Research. 2: 139-149. PMID 28352383 DOI: 10.4021/cr71w  0.059
2007 Cohen-Wolkowiez M, Smith PB, Mangum B, Steinbach WJ, Alexander BD, Cotten CM, Clark RH, Walsh TJ, Benjamin DK. Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. Journal of Perinatology : Official Journal of the California Perinatal Association. 27: 97-100. PMID 17080094 DOI: 10.1038/sj.jp.7211628  0.059
2024 Smith LE, Escobar T, McCabe A, Grafton J, Higgins M, Littlefield M, Ray S, Leung P, Fiksdal A, Khinkar RM, Wilcox RB, Yuse C, Fillipon K, Walsh T, Morris CA, et al. Optimization of Patient Progression in a New Era: A Comprehensive Framework. Professional Case Management. PMID 38421734 DOI: 10.1097/NCM.0000000000000700  0.059
2022 Cao Y, Rudrakshala J, Williams R, Rodriguez S, Sorkhdini P, Yang AX, Mundy M, Yang D, Palmisciano A, Walsh T, Delcompare C, Caine T, Tomasi L, Shea BS, Zhou Y. CRTH2 Mediates Pro-fibrotic Macrophage Differentiation and Promotes Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. PMID 35585756 DOI: 10.1165/rcmb.2021-0504OC  0.059
2014 Minckler D, Small KW, Walsh TJ. Clinical and pathologic features of Bipolaris endophthalmitis after intravitreal triamcinolone. Jama Ophthalmology. 132: 630-2. PMID 24626426 DOI: 10.1001/jamaophthalmol.2014.257  0.059
2009 Eisenberg ML, Lee KL, Breyer BN, Walsh TJ, Konety BR, Stoller ML. Differences in quantitative urine composition in stone-forming versus unaffected mate kidneys. Open Access Journal of Urology. 1: 9-13. PMID 24198607  0.059
2013 Shah S, Schrader KA, Waanders E, Timms AE, Vijai J, Miething C, Wechsler J, Yang J, Hayes J, Klein RJ, Zhang J, Wei L, Wu G, Rusch M, Nagahawatte P, ... ... Walsh T, et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nature Genetics. 45: 1226-31. PMID 24013638 DOI: 10.1038/Ng.2754  0.059
2015 Walsh TJ, Shores MM, Fox AE, Moore KP, Forsberg CW, Kinsey CE, Heckbert SR, Zeliadt S, Thompson ML, Smith NL, Matsumoto AM. Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans. Andrology. 3: 287-92. PMID 25684636 DOI: 10.1111/andr.12014  0.059
2002 Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. The New England Journal of Medicine. 346: 225-34. PMID 11807146 DOI: 10.1056/Nejm200201243460403  0.059
2015 Chatzimoschou A, Simitsopoulou M, Antachopoulos C, Walsh TJ, Roilides E. Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 59: 2198-205. PMID 25645829 DOI: 10.1128/AAC.04934-14  0.059
2019 Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, et al. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leukemia & Lymphoma. 1-4. PMID 30741059 DOI: 10.1080/10428194.2018.1543877  0.059
2018 Gamaletsou MN, Walsh TJ, Sipsas NV. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies. Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology. PMID 29391334 DOI: 10.4274/tjh.2018.0007  0.058
2003 Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, Filioti J, Tsivitanidou M, Sofianou D, Kremenopoulos G, Walsh TJ. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. Journal of Clinical Microbiology. 41: 735-41. PMID 12574275 DOI: 10.1128/JCM.41.2.735-741.2003  0.058
2013 Walsh TJ, Gamaletsou MN. Treatment of fungal disease in the setting of neutropenia. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2013: 423-7. PMID 24319214 DOI: 10.1182/asheducation-2013.1.423  0.058
2023 Nguyen MH, Ostrosky-Zeichner L, Pappas PG, Walsh TJ, Bubalo J, Alexander BD, Miceli MH, Jiang J, Song Y, Thompson GR. Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry. Open Forum Infectious Diseases. 10: ofad424. PMID 37674634 DOI: 10.1093/ofid/ofad424  0.058
2009 Hotaling JM, Walsh TJ. Male infertility: a risk factor for testicular cancer. Nature Reviews. Urology. 6: 550-6. PMID 19724246 DOI: 10.1038/nrurol.2009.179  0.058
2013 Zhao Y, Petraitiene R, Walsh TJ, Perlin DS. A real-time PCR assay for rapid detection and quantification of Exserohilum rostratum, a causative pathogen of fungal meningitis associated with injection of contaminated methylprednisolone. Journal of Clinical Microbiology. 51: 1034-6. PMID 23303500 DOI: 10.1128/JCM.03369-12  0.058
2011 Cooley SM, Donnelly JC, Walsh T, Collins C, McMahon C, Gillan J, Geary MP. The impact of positive acquired thrombophilia serology on ultrasound, obstetric outcome and the placenta in a low-risk primigravid population. Obstetric Medicine. 4: 15-9. PMID 27579090 DOI: 10.1258/om.2010.100057  0.058
2012 Antachopoulos C, Walsh TJ. Immunotherapy of Cryptococcus infections. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 18: 126-33. PMID 22264261 DOI: 10.1111/j.1469-0691.2011.03741.x  0.058
2011 Disraelly DS, Walsh TJ, Zirkle RA, Curling CA. A new methodology for estimating nerve agent (Sarin (GB)/VX) casualties as a function of time: Defining the Human Response Injury Profile nerve agent methodology Journal of Chemical Health and Safety. 18: 5-11. DOI: 10.1016/j.jchas.2010.09.001  0.058
2006 Antachopoulos C, Meletiadis J, Roilides E, Sein T, Sutton DA, Wickes BL, Rinaldi MG, Merz WG, Shea YR, Walsh TJ. Relationship between metabolism and biomass of medically important zygomycetes. Medical Mycology. 44: 429-38. PMID 16882609 DOI: 10.1080/13693780600644878  0.058
2018 Healy P, McCrone L, Tully R, Flannery E, Flynn A, Cahir C, Arumugasamy M, Walsh T. Virtual outpatient clinic as an alternative to an actual clinic visit after surgical discharge: a randomised controlled trial. Bmj Quality & Safety. PMID 30291181 DOI: 10.1136/bmjqs-2018-008171  0.057
2021 Hoenigl M, Salmanton-García J, Walsh TJ, Nucci M, Neoh CF, Jenks JD, Lackner M, Sprute R, Al-Hatmi AMS, Bassetti M, Carlesse F, Freiberger T, Koehler P, Lehrnbecher T, Kumar A, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. The Lancet. Infectious Diseases. PMID 33606997 DOI: 10.1016/S1473-3099(20)30784-2  0.057
2007 Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: 2-12. PMID 17143808 DOI: 10.1086/508774  0.057
2010 Garcia MM, Ohta AT, Walsh TJ, Vittinghof E, Lin G, Wu MC, Lue TF. A noninvasive, motility independent, sperm sorting method and technology to identify and retrieve individual viable nonmotile sperm for intracytoplasmic sperm injection. The Journal of Urology. 184: 2466-72. PMID 20952004 DOI: 10.1016/J.Juro.2010.08.026  0.057
2017 Huppler AR, Fisher BT, Lehrnbecher T, Walsh TJ, Steinbach WJ. Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children. Journal of the Pediatric Infectious Diseases Society. 6: S32-S44. PMID 28927202 DOI: 10.1093/jpids/pix054  0.057
2003 Roilides E, Lyman CA, Sein T, Petraitiene R, Walsh TJ. Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes against Penicillium marneffei conidia. Fems Immunology and Medical Microbiology. 36: 19-26. PMID 12727361 DOI: 10.1016/S0928-8244(03)00035-X  0.057
2019 Armellino D, Goldstein K, Thomas L, Walsh TJ, Petraitis V. Comparative evaluation of operating room terminal cleaning by two methods: Focused multivector ultraviolet (FMUV) versus manual-chemical disinfection. American Journal of Infection Control. PMID 31796341 DOI: 10.1016/j.ajic.2019.10.009  0.057
2005 Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. The Journal of Infectious Diseases. 191: 1350-60. PMID 15776383 DOI: 10.1086/428780  0.057
2018 Liu W, Walsh T. The Impact of Implementation of a Clinically Integrated Problem-Based Neonatal Electronic Health Record on Documentation Metrics, Provider Satisfaction, and Hospital Reimbursement: A Quality Improvement Project. Jmir Medical Informatics. 6: e40. PMID 29925495 DOI: 10.2196/medinform.9776  0.057
2017 Jacobs SE, Saez-Lacy D, Wynkoop W, Walsh TJ. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature. Open Forum Infectious Diseases. 4: ofx040. PMID 28491888 DOI: 10.1093/ofid/ofx040  0.057
2019 Arrieta AC, Sung L, Bradley JS, Zwaan CM, Gates D, Waskin H, Carmelitano P, Groll AH, Lehrnbecher T, Mangin E, Joshi A, Kartsonis NA, Walsh TJ, Paschke A. A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia. Plos One. 14: e0212837. PMID 30913226 DOI: 10.1371/Journal.Pone.0212837  0.057
2008 Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 674-83. PMID 18637757 DOI: 10.1086/590566  0.057
2016 Lestner JM, Groll AH, Aljayyoussi G, Seibel NL, Shad A, Gonzalez C, Wood LV, Jarosinski PF, Walsh TJ, Hope WW. Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children. Antimicrobial Agents and Chemotherapy. PMID 27697762 DOI: 10.1128/AAC.01427-16  0.057
2011 Disraelly DS, Walsh TJ, Zirkle RA, Curling CA. A new methodology for estimating nerve agent (Sarin (GB)/VX) casualties as a function of time: Implementing the human response injury profile nerve agent methodology Journal of Chemical Health and Safety. 18: 12-16. DOI: 10.1016/j.jchas.2010.09.002  0.057
2010 Gonzales DA, De Torre C, Wang H, Devor CB, Munson PJ, Ying SX, Kern SJ, Petraitiene R, Levens DL, Walsh TJ, Suffredini AF. Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia. Proteomics. 10: 4270-80. PMID 21089047 DOI: 10.1002/pmic.200900768  0.056
2009 Valdez JM, Scheinberg P, Young NS, Walsh TJ. Infections in patients with aplastic anemia. Seminars in Hematology. 46: 269-76. PMID 19549579 DOI: 10.1053/j.seminhematol.2009.03.008  0.056
2019 Brisbane WG, Rogers MJ, Hsi RS, Rajanahally S, Schade GR, Trew L, Ostrowski KA, Wessells H, Walsh TJ. Comparison of clinician and patient users of a mobile phone application to assess penile curvature in Peyronie's disease. International Journal of Impotence Research. PMID 31068689 DOI: 10.1038/s41443-019-0150-y  0.056
2015 Ghannoum M, Roilides E, Katragkou A, Petraitis V, Walsh TJ. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: S618-21. PMID 26567279 DOI: 10.1093/cid/civ815  0.056
2004 Kordy FN, Al-Mohsen IZ, Hashem F, Almodovar E, Al Hajjar S, Walsh TJ. Successful treatment of a child with posttraumatic necrotizing fasciitis caused by Apophysomyces elegans: case report and review of literature. The Pediatric Infectious Disease Journal. 23: 877-9. PMID 15361732 DOI: 10.1097/01.INF.0000136870.17071.FD  0.056
2009 Roilides E, Zaoutis TE, Walsh TJ. Invasive zygomycosis in neonates and children. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 15: 50-4. PMID 19754758 DOI: 10.1111/j.1469-0691.2009.02981.x  0.056
2021 Cheng PJ, Kim J, Craig JR, Alukal J, Pastuszak AW, Walsh TJ, Hotaling JM. "The back-up vasectomy reversal." Simultaneous sperm retrieval and vasectomy reversal in the couple with advanced maternal age: a cost-effectiveness analysis. Urology. PMID 33812879 DOI: 10.1016/j.urology.2021.03.021  0.056
2022 Jacobs SE, Jacobs JL, Dennis EK, Taimur S, Rana M, Patel D, Gitman M, Patel G, Schaefer S, Iyer K, Moon J, Adams V, Lerner P, Walsh TJ, Zhu Y, et al. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents. Antimicrobial Agents and Chemotherapy. e0005322. PMID 35770999 DOI: 10.1128/aac.00053-22  0.056
2017 Petraitis V, Petraitiene R, Hope WW, Walsh TJ. Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis. Methods in Molecular Biology (Clifton, N.J.). 1625: 259-277. PMID 28584996 DOI: 10.1007/978-1-4939-7104-6_18  0.056
2008 Lamaris GA, Lewis RE, Chamilos G, May GS, Safdar A, Walsh TJ, Raad II, Kontoyiannis DP. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. The Journal of Infectious Diseases. 198: 186-92. PMID 18500936 DOI: 10.1086/589305  0.056
2000 Peak S, Walsh T, Benton C, Brake J, Van Horne P. Effects of Two Planes of Nutrition on Performance and Uniformity of Four Strains of Broiler Chicks Journal of Applied Poultry Research. 9: 185-194. DOI: 10.1093/JAPR/9.2.185  0.055
2008 Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 27: 245-51. PMID 18193305 DOI: 10.1007/s10096-007-0437-7  0.055
2015 Petraitiene R, Petraitis V, Bacher JD, Finkelman MA, Walsh TJ. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis. Medical Mycology. PMID 26129890 DOI: 10.1093/mmy/myv034  0.055
2007 Meletiadis J, Walsh TJ, Choi EH, Pappas PG, Ennis D, Douglas J, Pankey GA, Larsen RA, Hamill RJ, Chanock S. Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients. Medical Mycology. 45: 513-8. PMID 17710620 DOI: 10.1080/13693780701390140  0.055
2008 Lane JW, Rehak NN, Hortin GL, Zaoutis T, Krause PR, Walsh TJ. Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy. Clinica Chimica Acta; International Journal of Clinical Chemistry. 387: 145-9. PMID 17936740 DOI: 10.1016/j.cca.2007.08.008  0.055
2007 Simitsopoulou M, Roilides E, Likartsis C, Ioannidis J, Orfanou A, Paliogianni F, Walsh TJ. Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 51: 1048-54. PMID 17178797 DOI: 10.1128/AAC.01095-06  0.055
2009 Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1743-51. PMID 19435437 DOI: 10.1086/599105  0.055
2018 Benjamin DK, Kaufman DA, Hope WW, Smith PB, Arrieta A, Manzoni P, Kovanda LL, Lademacher C, Isaacson B, Jednachowski D, Wu C, Kaibara A, Walsh TJ. A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants with Invasive Candidiasis. The Pediatric Infectious Disease Journal. PMID 29596222 DOI: 10.1097/INF.0000000000001996  0.054
2014 Satlin MJ, Soave R, Racanelli AC, Shore TB, van Besien K, Jenkins SG, Walsh TJ. The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients. Leukemia & Lymphoma. 55: 2858-65. PMID 24559288 DOI: 10.3109/10428194.2014.896007  0.054
2011 Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Walsh TJ, Roilides E. Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 55: 5923-9. PMID 21911564 DOI: 10.1128/AAC.00548-11  0.054
2011 Torres Peralta R, Kaochar T, Fasel IR, Morrison CT, Walsh TJ, Cohen PR. Challenges to decoding the intention behind natural instruction Proceedings - Ieee International Workshop On Robot and Human Interactive Communication. 113-118. DOI: 10.1109/ROMAN.2011.6005273  0.054
2011 Moriyama B, Falade-Nwulia O, Leung J, Penzak SR, JJingo C, Huang X, Henning SA, Wilson WH, Walsh TJ. Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction. Mycoses. 54: e877-9. PMID 21615537 DOI: 10.1111/j.1439-0507.2011.02016.x  0.054
2018 McCarthy MW, Walsh TJ. The rise of hospitalists: An opportunity for infectious diseases investigators. Expert Review of Anti-Infective Therapy. PMID 29620478 DOI: 10.1080/14787210.2018.1462158  0.054
2009 Gordon KC, David G, Walsh TJ. Vibrational spectroscopy and quantum chemical studies of 1,6,7,12,13,18-hexaazatrinaphthylene and related compounds. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 72: 209-13. PMID 18783982 DOI: 10.1016/j.saa.2008.07.039  0.054
1980 Walsh TJ. Non-contact evaluation of carotid artery flow Neuro-Ophthalmology. 1: 11-17. DOI: 10.3109/01658108009004895  0.054
2013 Tay WT, Soria MF, Walsh T, Thomazoni D, Silvie P, Behere GT, Anderson C, Downes S. A brave new world for an old world pest: Helicoverpa armigera (Lepidoptera: Noctuidae) in Brazil. Plos One. 8: e80134. PMID 24260345 DOI: 10.1371/journal.pone.0080134  0.054
2009 Walsh TJ. Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia. Seminars in Hematology. 46: 191-7. PMID 19549573 DOI: 10.1053/j.seminhematol.2009.05.001  0.054
2006 Cortez KJ, Lyman CA, Kottilil S, Kim HS, Roilides E, Yang J, Fullmer B, Lempicki R, Walsh TJ. Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infection and Immunity. 74: 2353-65. PMID 16552065 DOI: 10.1128/IAI.74.4.2353-2365.2006  0.054
2017 Corzo-León DE, Chora-Hernández LD, Rodríguez-Zulueta AP, Walsh TJ. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases. Medical Mycology. PMID 28431008 DOI: 10.1093/mmy/myx017  0.054
2012 Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S23-34. PMID 22247442 DOI: 10.1093/cid/cir866  0.054
2023 Faron M, Cheugoua-Zanetsie M, Tierney J, Thirion P, Nankivell M, Winter K, Yang H, Shapiro J, Vernerey D, Smithers BM, Walsh T, Piessen G, Nilsson M, Boonstra J, Ychou M, et al. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2202279. PMID 37467395 DOI: 10.1200/JCO.22.02279  0.054
2011 Disraelly DS, Walsh TJ, Curling CA. A new methodology for estimating contagious biological agent casualties as a function of time Mathematical and Computer Modelling. 54: 649-658. DOI: 10.1016/j.mcm.2011.03.008  0.054
2009 Pyrgos V, Ratanavanich K, Donegan N, Veis J, Walsh TJ, Shoham S. Candida bloodstream infections in hemodialysis recipients. Medical Mycology. 47: 463-7. PMID 18798046 DOI: 10.1080/13693780802369332  0.053
2022 Chen TK, Batra JS, Michalik DE, Casillas J, Patel R, Ruiz ME, Hara H, Patel B, Kadapakkam M, Ch'Ng J, Small CB, Zagaliotis P, Ragsdale CE, Leal LO, Roilides E, ... Walsh TJ, et al. Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases. Open Forum Infectious Diseases. 9: ofac535. PMID 36381625 DOI: 10.1093/ofid/ofac535  0.053
2014 Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, ... ... Walsh TJ, et al. Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. Journal of Clinical Microbiology. 52: 2199-201. PMID 24719434 DOI: 10.1128/Jcm.00285-14  0.053
2019 Hehemann MC, Walsh TJ. Orchiectomy as Bridge or Alternative to Vaginoplasty. The Urologic Clinics of North America. 46: 505-510. PMID 31582025 DOI: 10.1016/j.ucl.2019.07.005  0.053
2024 Rojanasarot S, Morris K, Nicholson T, Walsh T. Access to inflatable penile prosthesis surgery as indicated by distances traveled among US men with Medicare. Sexual Medicine. 12: qfad073. PMID 38348105 DOI: 10.1093/sexmed/qfad073  0.053
2007 Zaoutis T, Walsh TJ. Antifungal therapy for neonatal candidiasis. Current Opinion in Infectious Diseases. 20: 592-7. PMID 17975409 DOI: 10.1097/QCO.0b013e3282f1bec9  0.053
2019 Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DP. Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma. Journal of Fungi (Basel, Switzerland). 5. PMID 31277364 DOI: 10.3390/jof5030057  0.053
2015 Miller AO, Gamaletsou MN, Henry MW, Al-Hafez L, Hussain K, Sipsas NV, Kontoyiannis DP, Roilides E, Brause BD, Walsh TJ. Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention. Infectious Diseases (London, England). 47: 144-9. PMID 25539148 DOI: 10.3109/00365548.2014.974207  0.053
2019 Groll AH, Rijnders BJA, Walsh TJ, Adler-Moore J, Lewis RE, Brüggemann RJM. Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 68: S260-S274. PMID 31222253 DOI: 10.1093/Cid/Ciz076  0.053
2015 Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. How Biofilms Evade Host Defenses. Microbiology Spectrum. 3. PMID 26185085 DOI: 10.1128/microbiolspec.MB-0012-2014  0.053
2012 Goosby E, Von Zinkernagel D, Holmes C, Haroz D, Walsh T. Raising the bar: PEPFAR and new paradigms for global health. Journal of Acquired Immune Deficiency Syndromes (1999). 60: S158-62. PMID 22797738 DOI: 10.1097/QAI.0b013e31825d057c  0.052
2010 Palmore TN, Shea YR, Childs RW, Sherry RM, Walsh TJ. Fusarium proliferatum soft tissue infection at the site of a puncture by a plant: recovery, isolation, and direct molecular identification. Journal of Clinical Microbiology. 48: 338-42. PMID 19923491 DOI: 10.1128/JCM.01525-09  0.052
2016 Kovanda LL, Petraitiene R, Petraitis V, Walsh TJ, Desai A, Bonate P, Hope WW. Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints. The Journal of Antimicrobial Chemotherapy. PMID 27084921 DOI: 10.1093/jac/dkw098  0.052
2008 Pyrgos V, Shoham S, Walsh TJ. Pulmonary zygomycosis. Seminars in Respiratory and Critical Care Medicine. 29: 111-20. PMID 18365993 DOI: 10.1055/s-2008-1063850  0.052
Hide low-probability matches.